microRNA information: hsa-let-7b-5p
Section | ID | link |
---|---|---|
Mature name: | hsa-let-7b-5p | miRbase |
Accession: | MIMAT0000063 | miRbase |
Precursor name: | hsa-let-7b | miRbase |
Precursor accession: | MI0000063 | miRbase |
Symbol: | MIRLET7B | HGNC |
RefSeq ID: | NR_029479 | GenBank |
Sequence: | UGAGGUAGUAGGUUGUGUGGUU |
Reported expression in cancers: hsa-let-7b-5p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-let-7b-5p | acute myeloid leukemia | downregulation | "Among them miR-128a and -128b are significantly ov ......" | 18056805 | qPCR |
hsa-let-7b-5p | breast cancer | downregulation | "Previously we found that let-7 miRNAs were downreg ......" | 21826373 | |
hsa-let-7b-5p | breast cancer | downregulation | "The heterochronic microRNA let 7 inhibits cell mot ......" | 23339187 | |
hsa-let-7b-5p | breast cancer | downregulation | "Breast cancer specific TRAIL expression mediated b ......" | 25150312 | qPCR |
hsa-let-7b-5p | colon cancer | downregulation | "Recently let-7 miRNAs were found to regulate human ......" | 16651716 | |
hsa-let-7b-5p | colorectal cancer | upregulation | "Of the 99 mCRC patients we studied differential mi ......" | 23098991 | Microarray |
hsa-let-7b-5p | colorectal cancer | upregulation | "High expression of let-7 g was associated with a g ......" | 23932154 | |
hsa-let-7b-5p | head and neck cancer | deregulation | "Significance was determined using significance ana ......" | 18798260 | Microarray |
hsa-let-7b-5p | liver cancer | downregulation | "In present study we found that the tumor suppresso ......" | 21814544 | |
hsa-let-7b-5p | liver cancer | downregulation | "Downregulation of let-7 miRNA in many human cancer ......" | 22289550 | |
hsa-let-7b-5p | liver cancer | downregulation | "Let-7 family microRNAs have been reported to be do ......" | 24724096 | |
hsa-let-7b-5p | lung cancer | downregulation | "Reduced expression of the let 7 microRNAs in human ......" | 15172979 | |
hsa-let-7b-5p | lung cancer | downregulation | "Suppression of non small cell lung tumor developme ......" | 18308936 | |
hsa-let-7b-5p | lung cancer | downregulation | "Indeed some transcripts of the let-7 family that a ......" | 19275611 | |
hsa-let-7b-5p | lung cancer | downregulation | "Down-regulation of let-7 microRNA miRNA plays an i ......" | 20033209 | |
hsa-let-7b-5p | lung cancer | downregulation | "Most miRs including all members of the let-7 famil ......" | 20068076 | qPCR |
hsa-let-7b-5p | lung cancer | downregulation | "let 7b and miR 126 are down regulated in tumor tis ......" | 23029111 | qPCR |
hsa-let-7b-5p | melanoma | downregulation | "A microRNA expression screen was performed analyzi ......" | 18379589 | qPCR |
hsa-let-7b-5p | ovarian cancer | downregulation | "Using microRNA microarrays we identify several miR ......" | 18560586 | Microarray |
hsa-let-7b-5p | ovarian cancer | downregulation | "The aim of this study was to find specific profile ......" | 23542579 | Microarray; qPCR |
hsa-let-7b-5p | pancreatic cancer | upregulation | "The rapamycin effects centered on decreased mTOR-r ......" | 25576058 | |
hsa-let-7b-5p | prostate cancer | downregulation | "Previous work has shown reduced expression levels ......" | 20418948 | |
hsa-let-7b-5p | prostate cancer | downregulation | "Multiple tumor-suppressive miRNAs were downregulat ......" | 22719071 | |
hsa-let-7b-5p | sarcoma | downregulation | "We detected decreased expression levels of some le ......" | 21412931 |
Reported cancer pathway affected by hsa-let-7b-5p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-let-7b-5p | breast cancer | Wnt signaling pathway; Apoptosis pathway; Notch signaling pathway | "The miRNAs and their clusters such as the miR-200 ......" | 26712794 | |
hsa-let-7b-5p | breast cancer | Apoptosis pathway | "The tumor-suppressive let-7 family of microRNAs mi ......" | 27574028 | Western blot; Luciferase |
hsa-let-7b-5p | esophageal cancer | Epithelial mesenchymal transition pathway | "HMGA2 is down regulated by microRNA let 7 and asso ......" | 24612219 | |
hsa-let-7b-5p | head and neck cancer | Epithelial mesenchymal transition pathway | "The tumour suppressor roles of the let-7 family th ......" | 23340306 | |
hsa-let-7b-5p | liver cancer | Apoptosis pathway | "The let 7 family of microRNAs inhibits Bcl xL expr ......" | 20347499 | Western blot |
hsa-let-7b-5p | lung cancer | cell cycle pathway | "Reduced miR 31 and let 7 maintain the balance betw ......" | 22301433 | |
hsa-let-7b-5p | lung cancer | Epithelial mesenchymal transition pathway | "Specifically let-7 and miR-9 are deregulated in bo ......" | 23365639 | |
hsa-let-7b-5p | lung cancer | Apoptosis pathway | "Specifically following HDAC inhibition MYC which n ......" | 26915294 | |
hsa-let-7b-5p | lung squamous cell cancer | cell cycle pathway | "Flow cytometry analysis revealed these miRNAs indu ......" | 19688090 | Flow cytometry |
hsa-let-7b-5p | melanoma | cell cycle pathway | "MicroRNA let 7b targets important cell cycle molec ......" | 18379589 | |
hsa-let-7b-5p | melanoma | Epithelial mesenchymal transition pathway | "An exploratory miRNA analysis of 666 miRs by low d ......" | 20302635 | |
hsa-let-7b-5p | melanoma | Apoptosis pathway | "Let 7b and microRNA 199a inhibit the proliferation ......" | 23162627 | |
hsa-let-7b-5p | pancreatic cancer | cell cycle pathway | "The rapamycin effects centered on decreased mTOR-r ......" | 25576058 | |
hsa-let-7b-5p | pancreatic cancer | cell cycle pathway | "LIN28B suppresses microRNA let 7b expression to pr ......" | 26609473 | Flow cytometry; RNAi |
hsa-let-7b-5p | prostate cancer | cell cycle pathway | "Distinct microRNA expression profiles in prostate ......" | 22719071 | |
hsa-let-7b-5p | retinoblastoma | cell cycle pathway | "In addition hsa-miR-25 hsa-miR-18a and hsa-miR-20a ......" | 26730174 | |
hsa-let-7b-5p | sarcoma | Epithelial mesenchymal transition pathway | "Using miRNA microarrays capable of detecting a kno ......" | 24457375 | Cell proliferation assay; Cell Proliferation Assay |
Reported cancer prognosis affected by hsa-let-7b-5p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-let-7b-5p | acute myeloid leukemia | differentiation | "We studied miRNA expression of leukemic blasts of ......" | 20425795 | |
hsa-let-7b-5p | bladder cancer | poor survival | "A let 7 microRNA binding site polymorphism in the ......" | 27620744 | |
hsa-let-7b-5p | breast cancer | tumorigenesis; staging; malignant trasformation | "Let 7 family miRNAs regulate estrogen receptor alp ......" | 20535543 | Luciferase |
hsa-let-7b-5p | breast cancer | metastasis | "To identify microRNAs miRNA involved in metastasis ......" | 21057539 | |
hsa-let-7b-5p | breast cancer | drug resistance | "let 7 microRNAs induce tamoxifen sensitivity by do ......" | 21826373 | Luciferase |
hsa-let-7b-5p | breast cancer | tumorigenesis | "LIN28: a regulator of tumor suppressing activity o ......" | 22081076 | |
hsa-let-7b-5p | breast cancer | motility; metastasis; cell migration | "The heterochronic microRNA let 7 inhibits cell mot ......" | 23339187 | |
hsa-let-7b-5p | breast cancer | malignant trasformation | "Here we identified 33 miRNAs with similar deregula ......" | 24104550 | |
hsa-let-7b-5p | breast cancer | drug resistance | "Breast cancer specific TRAIL expression mediated b ......" | 25150312 | Luciferase |
hsa-let-7b-5p | breast cancer | metastasis; motility | "Among these we identified miRNAs previously associ ......" | 25277099 | |
hsa-let-7b-5p | breast cancer | recurrence | "Multiple Let-7 family members were negatively corr ......" | 26717565 | |
hsa-let-7b-5p | breast cancer | drug resistance | "Specifically we will discuss key miRNAs involved i ......" | 27721895 | |
hsa-let-7b-5p | colon cancer | staging | "Association study of the let 7 miRNA complementary ......" | 24727325 | |
hsa-let-7b-5p | colon cancer | metastasis | "Nine dysregulated miRNA pairs fell into three miRN ......" | 25287248 | |
hsa-let-7b-5p | colorectal cancer | poor survival | "Genetic modulation of the Let 7 microRNA binding t ......" | 20177422 | |
hsa-let-7b-5p | colorectal cancer | drug resistance; poor survival | "A let 7 microRNA binding site polymorphism in 3' u ......" | 20603437 | |
hsa-let-7b-5p | colorectal cancer | drug resistance | "We investigated this issue by profiling the expres ......" | 20881268 | |
hsa-let-7b-5p | colorectal cancer | staging; poor survival | "A let 7 microRNA SNP in the KRAS 3'UTR is prognost ......" | 21994416 | |
hsa-let-7b-5p | colorectal cancer | metastasis | "We investigated expression of the reported metasta ......" | 22120473 | |
hsa-let-7b-5p | colorectal cancer | drug resistance | "The LCS6 polymorphism in the binding site of let 7 ......" | 23324806 | |
hsa-let-7b-5p | colorectal cancer | worse prognosis | "High expression of let-7 g was associated with a g ......" | 23932154 | |
hsa-let-7b-5p | colorectal cancer | metastasis | "We investigated the expression of metastasis-assoc ......" | 24653631 | |
hsa-let-7b-5p | colorectal cancer | drug resistance | "We identified a miRNA profile that was analysed by ......" | 25197016 | |
hsa-let-7b-5p | colorectal cancer | staging | "We performed miRNA profiling of 1547 human miRNAs ......" | 26045793 | |
hsa-let-7b-5p | colorectal cancer | progression | "rs712 polymorphism within let 7 microRNA binding s ......" | 26543374 | |
hsa-let-7b-5p | colorectal cancer | progression | "Of these 3 upregulated let-7b miR-1290 and miR-126 ......" | 27698796 | |
hsa-let-7b-5p | colorectal cancer | poor survival; immune evasion; immune resistance; worse prognosis | "MicroRNA let 7 T cells and patient survival in col ......" | 27737877 | |
hsa-let-7b-5p | esophageal cancer | metastasis; tumorigenesis | "Role of microRNA let 7 and effect to HMGA2 in esop ......" | 21598109 | Western blot |
hsa-let-7b-5p | gastric cancer | metastasis; tumorigenesis | "Let 7 microRNA family is selectively secreted into ......" | 20949044 | Western blot |
hsa-let-7b-5p | gastric cancer | metastasis; tumorigenesis | "MicroRNA let 7b suppresses human gastric cancer ma ......" | 25613480 | Luciferase; Western blot |
hsa-let-7b-5p | head and neck cancer | metastasis; poor survival | "Let-7 has been shown to function as a tumour suppr ......" | 21292542 | |
hsa-let-7b-5p | liver cancer | motility; drug resistance | "We evaluated the expression of microRNA in human H ......" | 21352471 | |
hsa-let-7b-5p | liver cancer | tumorigenesis | "In the present study we analyzed mCRP expression i ......" | 24297460 | Western blot |
hsa-let-7b-5p | lung cancer | poor survival | "Reduced expression of the let 7 microRNAs in human ......" | 15172979 | |
hsa-let-7b-5p | lung cancer | differentiation | "Reduced miR 31 and let 7 maintain the balance betw ......" | 22301433 | |
hsa-let-7b-5p | lung cancer | poor survival | "let 7b and miR 126 are down regulated in tumor tis ......" | 23029111 | |
hsa-let-7b-5p | lung cancer | drug resistance | "For better understanding of the cellular response ......" | 25451482 | |
hsa-let-7b-5p | lung cancer | poor survival | "Specifically following HDAC inhibition MYC which n ......" | 26915294 | |
hsa-let-7b-5p | lung squamous cell cancer | progression | "Flow cytometry analysis revealed these miRNAs indu ......" | 19688090 | Flow cytometry |
hsa-let-7b-5p | lung squamous cell cancer | metastasis; staging; poor survival | "Different members of let-7 family have been report ......" | 23981581 | |
hsa-let-7b-5p | lung squamous cell cancer | poor survival | "Systemic nanodelivery of miR-34 and let-7 suppress ......" | 25174400 | |
hsa-let-7b-5p | lung squamous cell cancer | drug resistance | "Combinatorial Action of MicroRNAs let 7 and miR 34 ......" | 25714397 | |
hsa-let-7b-5p | melanoma | malignant trasformation; progression | "MicroRNA let 7b targets important cell cycle molec ......" | 18379589 | |
hsa-let-7b-5p | melanoma | metastasis; differentiation | "An exploratory miRNA analysis of 666 miRs by low d ......" | 20302635 | |
hsa-let-7b-5p | melanoma | progression | "In situ analysis of melanoma samples using progres ......" | 23728176 | |
hsa-let-7b-5p | melanoma | differentiation | "Let-7 microRNAs miRNAs are highly conserved well-e ......" | 25669981 | |
hsa-let-7b-5p | ovarian cancer | worse prognosis | "The microRNA expression profiles were examined usi ......" | 18451233 | |
hsa-let-7b-5p | ovarian cancer | worse prognosis | "We highlight the role of the let-7 and miR-200 fam ......" | 20083225 | |
hsa-let-7b-5p | ovarian cancer | drug resistance | "Luciferase assays and real-time PCRs showed that t ......" | 21109987 | Luciferase |
hsa-let-7b-5p | ovarian cancer | drug resistance | "Let-7 is a family of small non-coding RNAs regulat ......" | 21571355 | |
hsa-let-7b-5p | ovarian cancer | worse prognosis; staging | "Two families of miRNAs miR-200 and let-7 are frequ ......" | 23237306 | |
hsa-let-7b-5p | ovarian cancer | differentiation | "These overwhelmingly observed oncogenic genes were ......" | 24129674 | |
hsa-let-7b-5p | ovarian cancer | tumorigenesis | "To explore miRNAs involved in the tumorigenesis in ......" | 25273528 | |
hsa-let-7b-5p | ovarian cancer | motility | "LncRNA HOST2 regulates cell biological behaviors i ......" | 25292198 | |
hsa-let-7b-5p | pancreatic cancer | progression | "let 7 MicroRNA transfer in pancreatic cancer deriv ......" | 19323605 | |
hsa-let-7b-5p | pancreatic cancer | poor survival | "The expression of miR-21 was significantly higher ......" | 21139804 | |
hsa-let-7b-5p | pancreatic cancer | tumorigenesis | "miR-122 let-7 family and miR-101 are down-regulate ......" | 22303361 | |
hsa-let-7b-5p | pancreatic cancer | metastasis | "We therefore established a screening strategy to f ......" | 23733161 | Western blot |
hsa-let-7b-5p | pancreatic cancer | poor survival | "The rapamycin effects centered on decreased mTOR-r ......" | 25576058 | |
hsa-let-7b-5p | pancreatic cancer | staging | "In addition from 10 to 50 weeks of age stage-speci ......" | 26516699 | |
hsa-let-7b-5p | pancreatic cancer | drug resistance | "In particular modulations of let-7 miR-29a miR-17- ......" | 27539232 | |
hsa-let-7b-5p | prostate cancer | progression; poor survival | "Distinct microRNA expression profile in prostate c ......" | 23798998 | |
hsa-let-7b-5p | prostate cancer | drug resistance; metastasis | "Loss of let 7 microRNA upregulates IL 6 in bone ma ......" | 23977098 | Luciferase |
hsa-let-7b-5p | prostate cancer | malignant trasformation | "Role of miRNA let 7 and its major targets in prost ......" | 25276782 | |
hsa-let-7b-5p | prostate cancer | worse prognosis | "miRNA let 7b modulates macrophage polarization and ......" | 27157642 | |
hsa-let-7b-5p | retinoblastoma | metastasis | "In addition hsa-miR-25 hsa-miR-18a and hsa-miR-20a ......" | 26730174 | |
hsa-let-7b-5p | sarcoma | malignant trasformation | "Let 7 microRNA and HMGA2 levels of expression are ......" | 21412931 | |
hsa-let-7b-5p | thyroid cancer | differentiation | "Effects of let 7 microRNA on Cell Growth and Diffe ......" | 19956384 |
Reported gene related to hsa-let-7b-5p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-let-7b-5p | bladder cancer | KRAS | "A let 7 microRNA binding site polymorphism in the ......" | 27620744 |
hsa-let-7b-5p | colon cancer | KRAS | "Association study of the let 7 miRNA complementary ......" | 24727325 |
hsa-let-7b-5p | colorectal cancer | KRAS | "A let 7 microRNA binding site polymorphism in 3' u ......" | 20603437 |
hsa-let-7b-5p | colorectal cancer | KRAS | "Let 7 microRNA binding site polymorphism in the 3' ......" | 24890702 |
hsa-let-7b-5p | colorectal cancer | KRAS | "The LCS6 polymorphism in the binding site of let 7 ......" | 23324806 |
hsa-let-7b-5p | colorectal cancer | KRAS | "A let 7 microRNA SNP in the KRAS 3'UTR is prognost ......" | 21994416 |
hsa-let-7b-5p | colorectal cancer | KRAS | "Let 7 miRNA binding site polymorphism in the KRAS ......" | 23167843 |
hsa-let-7b-5p | colorectal cancer | KRAS | "Genetic modulation of the Let 7 microRNA binding t ......" | 20177422 |
hsa-let-7b-5p | colorectal cancer | KRAS | "A let 7 microRNA binding site polymorphism in KRAS ......" | 25183481 |
hsa-let-7b-5p | colorectal cancer | KRAS | "Our results showed that miR-143 but not let-7b inc ......" | 26581910 |
hsa-let-7b-5p | colorectal cancer | KRAS | "Preclinical and experimental data in vivo indicate ......" | 22584434 |
hsa-let-7b-5p | lung squamous cell cancer | KRAS | "A SNP in a let 7 microRNA complementary site in th ......" | 18922928 |
hsa-let-7b-5p | pancreatic cancer | KRAS | "Interestingly the differential expression of miRNA ......" | 26516699 |
hsa-let-7b-5p | esophageal cancer | HMGA2 | "Role of microRNA let 7 and effect to HMGA2 in esop ......" | 21598109 |
hsa-let-7b-5p | esophageal cancer | HMGA2 | "HMGA2 is down regulated by microRNA let 7 and asso ......" | 24612219 |
hsa-let-7b-5p | gastric cancer | HMGA2 | "Since let-7 miRNAs generally play a tumor-suppress ......" | 20949044 |
hsa-let-7b-5p | gastric cancer | HMGA2 | "Recent studies report that HMGA2 is negatively reg ......" | 18413822 |
hsa-let-7b-5p | lung cancer | HMGA2 | "MiR-98 a member in the let-7 family acts as a nega ......" | 23700794 |
hsa-let-7b-5p | ovarian cancer | HMGA2 | "HMGA2 mRNA and let-7 family microRNA were detected ......" | 23073586 |
hsa-let-7b-5p | sarcoma | HMGA2 | "Let 7 microRNA and HMGA2 levels of expression are ......" | 21412931 |
hsa-let-7b-5p | colorectal cancer | HRAS | "On the basis of these data we suggest that the dow ......" | 20881268 |
hsa-let-7b-5p | glioblastoma | HRAS | "Transfection of let-7 miRNA reduced expression of ......" | 20607356 |
hsa-let-7b-5p | lung cancer | HRAS | "Using an established orthotopic mouse lung cancer ......" | 18344688 |
hsa-let-7b-5p | lung cancer | HRAS | "k-Ras and c-Myc two key oncogenes in lung cancer h ......" | 20033209 |
hsa-let-7b-5p | pancreatic cancer | HRAS | "Because let-7 microRNA targets the K-ras oncogene ......" | 19323605 |
hsa-let-7b-5p | breast cancer | EGFR | "The tumours in the TMAs were assigned to subtypes ......" | 22294324 |
hsa-let-7b-5p | colorectal cancer | EGFR | "The LCS6 polymorphism in the binding site of let 7 ......" | 23324806 |
hsa-let-7b-5p | lung cancer | EGFR | "Our mathematical model explains the signaling link ......" | 23365639 |
hsa-let-7b-5p | lung squamous cell cancer | EGFR | "This effect was observed over a wide range of miRN ......" | 25714397 |
hsa-let-7b-5p | breast cancer | LIN28A | "Moreover further studies showed that p21 Rb and Le ......" | 22808086 |
hsa-let-7b-5p | breast cancer | LIN28A | "LIN28 is a RNA-binding protein that has been well ......" | 22081076 |
hsa-let-7b-5p | breast cancer | LIN28A | "The Wnt β catenin pathway represses let 7 microRN ......" | 23613467 |
hsa-let-7b-5p | prostate cancer | LIN28A | "Furthermore let-7c expression is downregulated in ......" | 22479342 |
hsa-let-7b-5p | liver cancer | BCL2L1 | "The let 7 family of microRNAs inhibits Bcl xL expr ......" | 20347499 |
hsa-let-7b-5p | lung cancer | BCL2L1 | "As a result transcript levels of the tumor-suppres ......" | 26915294 |
hsa-let-7b-5p | melanoma | CCND1 | "The effect of let-7b on protein expression was due ......" | 18379589 |
hsa-let-7b-5p | melanoma | CCND1 | "Cyclin D1 expression was significantly higher in c ......" | 23162627 |
hsa-let-7b-5p | breast cancer | ERBB2 | "The tumours in the TMAs were assigned to subtypes ......" | 22294324 |
hsa-let-7b-5p | breast cancer | ERBB2 | "For instance an abundant expression of multiple le ......" | 25907662 |
hsa-let-7b-5p | breast cancer | ESR1 | "Let 7 family miRNAs regulate estrogen receptor alp ......" | 20535543 |
hsa-let-7b-5p | breast cancer | ESR1 | "let 7 microRNAs induce tamoxifen sensitivity by do ......" | 21826373 |
hsa-let-7b-5p | liver cancer | IL6 | "Knocking down IL-6 and Twist in HSCs significantly ......" | 21352471 |
hsa-let-7b-5p | prostate cancer | IL6 | "Loss of let 7 microRNA upregulates IL 6 in bone ma ......" | 23977098 |
hsa-let-7b-5p | melanoma | LIN28B | "Mechanistically we discovered that Lin28B a well-c ......" | 26071398 |
hsa-let-7b-5p | pancreatic cancer | LIN28B | "LIN28B suppresses microRNA let 7b expression to pr ......" | 26609473 |
hsa-let-7b-5p | lung cancer | MYC | "Our mathematical model explains the signaling link ......" | 23365639 |
hsa-let-7b-5p | lung cancer | MYC | "k-Ras and c-Myc two key oncogenes in lung cancer h ......" | 20033209 |
hsa-let-7b-5p | melanoma | PCNA | "The effect of let-7b on protein expression was due ......" | 18379589 |
hsa-let-7b-5p | melanoma | PCNA | "Cyclin D1 expression was significantly higher in c ......" | 23162627 |
hsa-let-7b-5p | melanoma | ADAR | "Importantly we discovered that ADAR1 fundamentally ......" | 23728176 |
hsa-let-7b-5p | liver cancer | AFP | "As a single marker α-fetoprotein AFP and miR-122 ......" | 26264553 |
hsa-let-7b-5p | lung cancer | BCL2 | "As a result transcript levels of the tumor-suppres ......" | 26915294 |
hsa-let-7b-5p | esophageal cancer | BRD2 | "Let-7 expressions were detected in esophageal canc ......" | 21598109 |
hsa-let-7b-5p | liver cancer | CD46 | "The present study suggests that CD46 plays an impo ......" | 24297460 |
hsa-let-7b-5p | prostate cancer | CFTR | "Validation of the data using an independent high-r ......" | 23798998 |
hsa-let-7b-5p | breast cancer | CTCFL | "Circulating cell free cancer testis MAGE A RNA BOR ......" | 24983365 |
hsa-let-7b-5p | gastric cancer | DDR1 | "Let-7 g improved the effects of X-rays on GC cells ......" | 25972194 |
hsa-let-7b-5p | melanoma | DICER1 | "Importantly we discovered that ADAR1 fundamentally ......" | 23728176 |
hsa-let-7b-5p | colorectal cancer | EZH2 | "Significant inverse correlation between EZH2 and h ......" | 25611389 |
hsa-let-7b-5p | B cell lymphoma | GBA | "Let-7 in particular let-7b is overexpressed in DLB ......" | 20651244 |
hsa-let-7b-5p | prostate cancer | HMGA1 | "Furthermore we identified HMGA1 a non-histone prot ......" | 23798998 |
hsa-let-7b-5p | head and neck cancer | HMI | "Subsequently microarray analysis followed by Ingen ......" | 27588466 |
hsa-let-7b-5p | gastric cancer | ING1 | "MicroRNA let 7b suppresses human gastric cancer ma ......" | 25613480 |
hsa-let-7b-5p | breast cancer | KDM5B | "In MCF-7 cells with stable RNAi-mediated suppressi ......" | 21969366 |
hsa-let-7b-5p | lung squamous cell cancer | LCS1 | "The purpose of this study was to identify single n ......" | 18922928 |
hsa-let-7b-5p | breast cancer | LMNA | "Twenty-five differentially expressed miRNAs P < 0. ......" | 20535543 |
hsa-let-7b-5p | pancreatic cancer | MAP2K6 | "Restoring let-7 levels in cancer-derived cell line ......" | 19323605 |
hsa-let-7b-5p | head and neck cancer | MMP8 | "However the role of let-7 in head and neck cancer ......" | 21292542 |
hsa-let-7b-5p | lung cancer | MVD | "We demonstrated significantly higher MVD and decre ......" | 23029111 |
hsa-let-7b-5p | head and neck cancer | NANOG | "Most importantly overexpression of let-7 or knockd ......" | 21292542 |
hsa-let-7b-5p | thyroid cancer | NKX2-1 | "In addition let-7 enhanced transcriptional express ......" | 19956384 |
hsa-let-7b-5p | glioblastoma | NRAS | "Transfection of let-7 miRNA reduced expression of ......" | 20607356 |
hsa-let-7b-5p | gastric cancer | PGC | "This study examined the expression patterns of ser ......" | 25549793 |
hsa-let-7b-5p | ovarian cancer | PGRMC1 | "In conclusion we propose that PGRMC1 expression is ......" | 21109987 |
hsa-let-7b-5p | B cell lymphoma | PRDM1 | "Data obtained from expression analysis luciferase ......" | 20651244 |
hsa-let-7b-5p | breast cancer | RAD52 | "We found that individuals with AC OR 0.684 95%CI 0 ......" | 27726100 |
hsa-let-7b-5p | lung squamous cell cancer | SCLC1 | "Among them five downregulated miRNAs let-7 miR-20 ......" | 23117485 |
hsa-let-7b-5p | sarcoma | SERPINH1 | "Using a quantitative shotgun proteomics approach w ......" | 24457375 |
hsa-let-7b-5p | pancreatic cancer | SOCS3 | "MicroRNA let 7 downregulates STAT3 phosphorylation ......" | 24491408 |
hsa-let-7b-5p | colon cancer | STAB2 | "Nine dysregulated miRNA pairs fell into three miRN ......" | 25287248 |
hsa-let-7b-5p | pancreatic cancer | STAT3 | "MicroRNA let 7 downregulates STAT3 phosphorylation ......" | 24491408 |
hsa-let-7b-5p | breast cancer | TAM | "Transfection of let-7 mimics to Tam-resistant MCF7 ......" | 21826373 |
hsa-let-7b-5p | ovarian cancer | TCF7L1 | "These overwhelmingly observed oncogenic genes were ......" | 24129674 |
hsa-let-7b-5p | colorectal cancer | TGFBR1 | "rs868 is contained in a let-7 miRNA binding site i ......" | 27234654 |
hsa-let-7b-5p | liver cancer | TRIM71 | "Lin-41 is a stem cell-specific E3 ligase and a kno ......" | 23097274 |
hsa-let-7b-5p | liver cancer | TWIST1 | "Knocking down IL-6 and Twist in HSCs significantly ......" | 21352471 |
hsa-let-7b-5p | sarcoma | VIM | "Using a quantitative shotgun proteomics approach w ......" | 24457375 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-let-7b-5p | ARID3A | 11 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.27; TCGA BRCA -0.236; TCGA CESC -0.454; TCGA COAD -0.428; TCGA ESCA -0.437; TCGA LIHC -0.379; TCGA LUAD -0.435; TCGA LUSC -0.308; TCGA PAAD -0.421; TCGA STAD -0.284; TCGA UCEC -0.278 |
hsa-let-7b-5p | ATP6V0A1 | 9 cancers: BLCA; CESC; ESCA; KIRP; LIHC; PAAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.099; TCGA CESC -0.09; TCGA ESCA -0.132; TCGA KIRP -0.175; TCGA LIHC -0.116; TCGA PAAD -0.486; TCGA SARC -0.092; TCGA THCA -0.116; TCGA STAD -0.242 |
hsa-let-7b-5p | CDC34 | 15 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BLCA -0.114; TCGA BRCA -0.354; TCGA CESC -0.13; TCGA COAD -0.152; TCGA HNSC -0.382; TCGA KIRP -0.152; TCGA LGG -0.186; TCGA LIHC -0.126; TCGA LUAD -0.277; TCGA LUSC -0.318; TCGA OV -0.163; TCGA PAAD -0.44; TCGA THCA -0.241; TCGA STAD -0.131; TCGA UCEC -0.166 |
hsa-let-7b-5p | CENPV | 9 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUSC; OV; SARC; UCEC | miRNAWalker2 validate | TCGA BLCA -0.253; TCGA CESC -0.31; TCGA ESCA -0.654; TCGA HNSC -0.458; TCGA KIRC -0.298; TCGA LUSC -0.403; TCGA OV -0.337; TCGA SARC -0.426; TCGA UCEC -0.408 |
hsa-let-7b-5p | CKB | 13 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LGG; OV; PAAD; PRAD; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.42; TCGA BRCA -0.158; TCGA CESC -0.416; TCGA HNSC -0.464; TCGA KIRC -0.694; TCGA KIRP -0.403; TCGA LGG -0.164; TCGA OV -0.306; TCGA PAAD -0.839; TCGA PRAD -0.153; TCGA SARC -0.428; TCGA STAD -0.664; TCGA UCEC -0.362 |
hsa-let-7b-5p | DPYSL5 | 10 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LUSC; OV; SARC; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.398; TCGA BRCA -0.568; TCGA CESC -0.572; TCGA HNSC -0.481; TCGA KIRP -0.352; TCGA LUSC -1.128; TCGA OV -1.076; TCGA SARC -0.648; TCGA STAD -0.966; TCGA UCEC -0.747 |
hsa-let-7b-5p | GDF11 | 9 cancers: BLCA; BRCA; CESC; ESCA; LUSC; OV; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BLCA -0.15; TCGA BRCA -0.081; TCGA CESC -0.423; TCGA ESCA -0.261; TCGA LUSC -0.294; TCGA OV -0.374; TCGA PAAD -0.325; TCGA STAD -0.282; TCGA UCEC -0.158 |
hsa-let-7b-5p | GYG1 | 9 cancers: BLCA; COAD; KIRC; KIRP; LIHC; PAAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.194; TCGA COAD -0.116; TCGA KIRC -0.101; TCGA KIRP -0.082; TCGA LIHC -0.069; TCGA PAAD -0.343; TCGA SARC -0.348; TCGA THCA -0.157; TCGA STAD -0.252 |
hsa-let-7b-5p | LIN28B | 11 cancers: BLCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; OV; SARC; STAD; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP; RAID | TCGA BLCA -0.509; TCGA CESC -0.616; TCGA ESCA -1.023; TCGA HNSC -1.027; TCGA LIHC -1.87; TCGA LUAD -1.06; TCGA LUSC -1.315; TCGA OV -1.817; TCGA SARC -0.7; TCGA STAD -0.678; TCGA UCEC -0.814 |
hsa-let-7b-5p | NSMCE4A | 10 cancers: BLCA; ESCA; HNSC; KIRP; LGG; LIHC; LUSC; OV; PAAD; SARC | miRNAWalker2 validate | TCGA BLCA -0.115; TCGA ESCA -0.116; TCGA HNSC -0.236; TCGA KIRP -0.075; TCGA LGG -0.127; TCGA LIHC -0.112; TCGA LUSC -0.17; TCGA OV -0.095; TCGA PAAD -0.139; TCGA SARC -0.091 |
hsa-let-7b-5p | PPP1R12C | 13 cancers: BLCA; BRCA; CESC; COAD; HNSC; LGG; LIHC; LUAD; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BLCA -0.195; TCGA BRCA -0.156; TCGA CESC -0.094; TCGA COAD -0.095; TCGA HNSC -0.236; TCGA LGG -0.146; TCGA LIHC -0.099; TCGA LUAD -0.076; TCGA PAAD -0.484; TCGA PRAD -0.175; TCGA SARC -0.15; TCGA THCA -0.077; TCGA STAD -0.399 |
hsa-let-7b-5p | SLC25A4 | 12 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; SARC; THCA; STAD | miRNAWalker2 validate; miRNATAP | TCGA BLCA -0.259; TCGA BRCA -0.092; TCGA HNSC -0.373; TCGA KIRC -0.462; TCGA KIRP -0.279; TCGA LGG -0.061; TCGA LIHC -0.092; TCGA PAAD -0.54; TCGA PRAD -0.096; TCGA SARC -0.512; TCGA THCA -0.191; TCGA STAD -0.414 |
hsa-let-7b-5p | FIGNL2 | 9 cancers: BLCA; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; UCEC | MirTarget | TCGA BLCA -0.329; TCGA KIRC -0.181; TCGA LGG -0.142; TCGA LIHC -0.293; TCGA LUAD -0.277; TCGA LUSC -0.18; TCGA OV -0.275; TCGA PAAD -0.48; TCGA UCEC -0.72 |
hsa-let-7b-5p | KLHDC8B | 9 cancers: BLCA; BRCA; KIRP; LGG; LIHC; PRAD; SARC; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.171; TCGA BRCA -0.058; TCGA KIRP -0.08; TCGA LGG -0.147; TCGA LIHC -0.144; TCGA PRAD -0.081; TCGA SARC -0.254; TCGA STAD -0.181; TCGA UCEC -0.251 |
hsa-let-7b-5p | SLC17A9 | 9 cancers: BLCA; BRCA; CESC; ESCA; HNSC; LUAD; PRAD; THCA; UCEC | MirTarget | TCGA BLCA -0.246; TCGA BRCA -0.293; TCGA CESC -0.423; TCGA ESCA -1.198; TCGA HNSC -0.409; TCGA LUAD -0.188; TCGA PRAD -0.174; TCGA THCA -0.18; TCGA UCEC -0.294 |
hsa-let-7b-5p | DLGAP4 | 10 cancers: BLCA; BRCA; CESC; COAD; LGG; LUAD; OV; PAAD; THCA; STAD | MirTarget | TCGA BLCA -0.103; TCGA BRCA -0.095; TCGA CESC -0.101; TCGA COAD -0.096; TCGA LGG -0.054; TCGA LUAD -0.123; TCGA OV -0.054; TCGA PAAD -0.2; TCGA THCA -0.16; TCGA STAD -0.154 |
hsa-let-7b-5p | TBKBP1 | 11 cancers: BLCA; ESCA; KIRP; LGG; LUAD; LUSC; OV; PAAD; PRAD; STAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.172; TCGA ESCA -0.22; TCGA KIRP -0.115; TCGA LGG -0.239; TCGA LUAD -0.237; TCGA LUSC -0.25; TCGA OV -0.282; TCGA PAAD -0.358; TCGA PRAD -0.092; TCGA STAD -0.27; TCGA UCEC -0.222 |
hsa-let-7b-5p | HIF3A | 9 cancers: BLCA; COAD; ESCA; HNSC; OV; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -1.287; TCGA COAD -0.571; TCGA ESCA -1.06; TCGA HNSC -0.79; TCGA OV -0.701; TCGA PRAD -0.609; TCGA SARC -0.425; TCGA STAD -0.68; TCGA UCEC -1.056 |
hsa-let-7b-5p | SLC8A2 | 10 cancers: BLCA; COAD; HNSC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.577; TCGA COAD -0.488; TCGA HNSC -0.525; TCGA LUAD -0.345; TCGA LUSC -0.662; TCGA PAAD -0.741; TCGA PRAD -0.238; TCGA SARC -0.664; TCGA STAD -0.846; TCGA UCEC -0.499 |
hsa-let-7b-5p | DOCK3 | 13 cancers: BLCA; BRCA; HNSC; KIRC; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BLCA -0.442; TCGA BRCA -0.352; TCGA HNSC -0.219; TCGA KIRC -1.186; TCGA LIHC -0.385; TCGA LUAD -0.266; TCGA LUSC -0.713; TCGA PAAD -0.559; TCGA PRAD -0.215; TCGA SARC -1.238; TCGA THCA -0.115; TCGA STAD -0.623; TCGA UCEC -0.324 |
hsa-let-7b-5p | RBM38 | 9 cancers: BLCA; BRCA; HNSC; LUAD; OV; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.103; TCGA BRCA -0.336; TCGA HNSC -0.277; TCGA LUAD -0.175; TCGA OV -0.124; TCGA PRAD -0.251; TCGA SARC -0.589; TCGA STAD -0.213; TCGA UCEC -0.229 |
hsa-let-7b-5p | HABP4 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; PAAD; PRAD; STAD | miRNATAP | TCGA BLCA -0.424; TCGA CESC -0.253; TCGA ESCA -0.389; TCGA HNSC -0.202; TCGA KIRC -0.311; TCGA KIRP -0.239; TCGA LGG -0.097; TCGA LIHC -0.306; TCGA PAAD -0.316; TCGA PRAD -0.093; TCGA STAD -0.196 |
hsa-let-7b-5p | SPEG | 12 cancers: BLCA; BRCA; COAD; HNSC; KIRC; LGG; LUAD; PAAD; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BLCA -0.691; TCGA BRCA -0.187; TCGA COAD -0.492; TCGA HNSC -0.397; TCGA KIRC -0.366; TCGA LGG -0.153; TCGA LUAD -0.236; TCGA PAAD -1.053; TCGA PRAD -0.604; TCGA SARC -0.838; TCGA STAD -0.861; TCGA UCEC -0.414 |
hsa-let-7b-5p | TUSC2 | 11 cancers: BLCA; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; PAAD; SARC; UCEC | miRNATAP | TCGA BLCA -0.137; TCGA COAD -0.096; TCGA ESCA -0.159; TCGA HNSC -0.218; TCGA KIRC -0.329; TCGA KIRP -0.06; TCGA LGG -0.054; TCGA LIHC -0.249; TCGA PAAD -0.144; TCGA SARC -0.197; TCGA UCEC -0.073 |
hsa-let-7b-5p | SPTBN4 | 12 cancers: BLCA; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD | miRNATAP | TCGA BLCA -0.391; TCGA ESCA -0.752; TCGA HNSC -0.218; TCGA KIRC -0.675; TCGA KIRP -0.449; TCGA LGG -0.113; TCGA LIHC -0.175; TCGA LUAD -0.178; TCGA LUSC -0.337; TCGA PAAD -1.179; TCGA SARC -0.383; TCGA STAD -0.37 |
hsa-let-7b-5p | AATF | 10 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.097; TCGA CESC -0.081; TCGA HNSC -0.141; TCGA KIRP -0.112; TCGA LIHC -0.246; TCGA LUAD -0.154; TCGA LUSC -0.191; TCGA SARC -0.119; TCGA THCA -0.052; TCGA UCEC -0.136 |
hsa-let-7b-5p | ABCB8 | 11 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.142; TCGA CESC -0.093; TCGA HNSC -0.08; TCGA KIRC -0.332; TCGA KIRP -0.161; TCGA LIHC -0.073; TCGA LUAD -0.117; TCGA LUSC -0.104; TCGA OV -0.106; TCGA PAAD -0.371; TCGA THCA -0.06 |
hsa-let-7b-5p | ABCF1 | 10 cancers: BRCA; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; OV; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.168; TCGA COAD -0.115; TCGA ESCA -0.11; TCGA KIRC -0.123; TCGA KIRP -0.076; TCGA LIHC -0.123; TCGA LUAD -0.132; TCGA OV -0.173; TCGA THCA -0.057; TCGA UCEC -0.127 |
hsa-let-7b-5p | ADRM1 | 13 cancers: BRCA; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.325; TCGA COAD -0.122; TCGA HNSC -0.17; TCGA KIRP -0.062; TCGA LGG -0.05; TCGA LIHC -0.158; TCGA LUAD -0.198; TCGA LUSC -0.17; TCGA OV -0.063; TCGA PAAD -0.223; TCGA SARC -0.132; TCGA THCA -0.138; TCGA UCEC -0.141 |
hsa-let-7b-5p | ALG3 | 11 cancers: BRCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.348; TCGA CESC -0.108; TCGA COAD -0.145; TCGA HNSC -0.163; TCGA KIRP -0.182; TCGA LIHC -0.23; TCGA LUAD -0.244; TCGA LUSC -0.467; TCGA SARC -0.108; TCGA THCA -0.077; TCGA UCEC -0.151 |
hsa-let-7b-5p | ANKZF1 | 9 cancers: BRCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC | miRNAWalker2 validate | TCGA BRCA -0.119; TCGA HNSC -0.261; TCGA LGG -0.184; TCGA LIHC -0.248; TCGA LUAD -0.22; TCGA LUSC -0.281; TCGA OV -0.069; TCGA PAAD -0.183; TCGA SARC -0.128 |
hsa-let-7b-5p | ASPSCR1 | 13 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.267; TCGA CESC -0.164; TCGA COAD -0.172; TCGA HNSC -0.356; TCGA KIRC -0.326; TCGA KIRP -0.205; TCGA LGG -0.203; TCGA LIHC -0.429; TCGA LUAD -0.204; TCGA LUSC -0.328; TCGA OV -0.155; TCGA PAAD -0.617; TCGA THCA -0.09 |
hsa-let-7b-5p | ATG4B | 11 cancers: BRCA; COAD; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BRCA -0.17; TCGA COAD -0.115; TCGA HNSC -0.221; TCGA KIRC -0.139; TCGA LGG -0.162; TCGA LIHC -0.119; TCGA LUAD -0.19; TCGA LUSC -0.192; TCGA OV -0.137; TCGA PAAD -0.235; TCGA UCEC -0.065 |
hsa-let-7b-5p | ATP6V1F | 10 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.273; TCGA COAD -0.105; TCGA HNSC -0.144; TCGA KIRC -0.273; TCGA KIRP -0.243; TCGA LIHC -0.196; TCGA LUSC -0.14; TCGA PAAD -0.221; TCGA THCA -0.256; TCGA UCEC -0.058 |
hsa-let-7b-5p | AURKA | 10 cancers: BRCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.602; TCGA HNSC -0.148; TCGA KIRP -0.25; TCGA LIHC -0.438; TCGA LUAD -0.624; TCGA LUSC -0.665; TCGA OV -0.176; TCGA SARC -0.214; TCGA THCA -0.115; TCGA UCEC -0.24 |
hsa-let-7b-5p | BZW2 | 11 cancers: BRCA; COAD; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; THCA; UCEC | miRNAWalker2 validate; MirTarget; miRNATAP | TCGA BRCA -0.179; TCGA COAD -0.124; TCGA ESCA -0.205; TCGA HNSC -0.087; TCGA KIRC -0.207; TCGA LIHC -0.205; TCGA LUAD -0.17; TCGA LUSC -0.264; TCGA OV -0.087; TCGA THCA -0.064; TCGA UCEC -0.139 |
hsa-let-7b-5p | CDC25A | 9 cancers: BRCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; THCA; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BRCA -0.487; TCGA HNSC -0.141; TCGA KIRC -0.426; TCGA LIHC -0.37; TCGA LUAD -0.583; TCGA LUSC -0.764; TCGA OV -0.254; TCGA THCA -0.102; TCGA UCEC -0.215 |
hsa-let-7b-5p | CMC1 | 9 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUSC; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.117; TCGA ESCA -0.152; TCGA HNSC -0.206; TCGA KIRC -0.37; TCGA KIRP -0.245; TCGA LIHC -0.275; TCGA LUSC -0.182; TCGA SARC -0.173; TCGA THCA -0.166 |
hsa-let-7b-5p | COX7B | 11 cancers: BRCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.216; TCGA HNSC -0.367; TCGA KIRC -0.518; TCGA KIRP -0.382; TCGA LIHC -0.157; TCGA LUAD -0.081; TCGA LUSC -0.243; TCGA PAAD -0.189; TCGA SARC -0.217; TCGA THCA -0.186; TCGA UCEC -0.077 |
hsa-let-7b-5p | CPSF1 | 9 cancers: BRCA; CESC; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.26; TCGA CESC -0.118; TCGA HNSC -0.164; TCGA LGG -0.154; TCGA LIHC -0.194; TCGA LUAD -0.285; TCGA LUSC -0.219; TCGA PAAD -0.23; TCGA THCA -0.06 |
hsa-let-7b-5p | CSNK1D | 11 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.069; TCGA CESC -0.075; TCGA COAD -0.082; TCGA ESCA -0.11; TCGA KIRC -0.076; TCGA KIRP -0.065; TCGA LIHC -0.192; TCGA LUAD -0.109; TCGA LUSC -0.156; TCGA PAAD -0.323; TCGA UCEC -0.062 |
hsa-let-7b-5p | DDX28 | 11 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; OV; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.149; TCGA COAD -0.103; TCGA HNSC -0.08; TCGA KIRC -0.236; TCGA KIRP -0.299; TCGA LGG -0.056; TCGA LIHC -0.118; TCGA LUSC -0.107; TCGA OV -0.069; TCGA PAAD -0.178; TCGA THCA -0.198 |
hsa-let-7b-5p | DDX49 | 10 cancers: BRCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.215; TCGA HNSC -0.164; TCGA KIRP -0.09; TCGA LGG -0.102; TCGA LIHC -0.209; TCGA LUAD -0.096; TCGA LUSC -0.256; TCGA OV -0.106; TCGA PAAD -0.214; TCGA THCA -0.158 |
hsa-let-7b-5p | DENR | 9 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD | miRNAWalker2 validate | TCGA BRCA -0.101; TCGA CESC -0.096; TCGA HNSC -0.063; TCGA KIRP -0.076; TCGA LIHC -0.089; TCGA LUAD -0.195; TCGA LUSC -0.25; TCGA OV -0.155; TCGA PAAD -0.142 |
hsa-let-7b-5p | E2F5 | 10 cancers: BRCA; CESC; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; OV; UCEC | miRNAWalker2 validate; MirTarget; miRNATAP | TCGA BRCA -0.209; TCGA CESC -0.276; TCGA ESCA -0.708; TCGA KIRC -0.393; TCGA KIRP -0.093; TCGA LIHC -0.219; TCGA LUAD -0.255; TCGA LUSC -0.281; TCGA OV -0.255; TCGA UCEC -0.236 |
hsa-let-7b-5p | E2F6 | 10 cancers: BRCA; COAD; HNSC; LIHC; LUAD; LUSC; OV; PAAD; PRAD; UCEC | miRNAWalker2 validate; miRNATAP | TCGA BRCA -0.099; TCGA COAD -0.098; TCGA HNSC -0.204; TCGA LIHC -0.177; TCGA LUAD -0.162; TCGA LUSC -0.219; TCGA OV -0.224; TCGA PAAD -0.141; TCGA PRAD -0.05; TCGA UCEC -0.099 |
hsa-let-7b-5p | EEF1E1 | 14 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.158; TCGA CESC -0.164; TCGA COAD -0.159; TCGA HNSC -0.334; TCGA KIRC -0.252; TCGA KIRP -0.105; TCGA LGG -0.091; TCGA LIHC -0.187; TCGA LUAD -0.206; TCGA LUSC -0.305; TCGA OV -0.146; TCGA PAAD -0.115; TCGA THCA -0.125; TCGA UCEC -0.149 |
hsa-let-7b-5p | ENTPD6 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.106; TCGA CESC -0.186; TCGA COAD -0.184; TCGA ESCA -0.192; TCGA HNSC -0.241; TCGA KIRC -0.268; TCGA KIRP -0.151; TCGA LGG -0.143; TCGA LIHC -0.108; TCGA LUAD -0.139; TCGA LUSC -0.201; TCGA PAAD -0.363; TCGA THCA -0.167 |
hsa-let-7b-5p | ERGIC2 | 9 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.156; TCGA CESC -0.092; TCGA HNSC -0.097; TCGA KIRP -0.107; TCGA LIHC -0.063; TCGA LUAD -0.157; TCGA LUSC -0.188; TCGA THCA -0.116; TCGA UCEC -0.087 |
hsa-let-7b-5p | FAM136A | 10 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV | miRNAWalker2 validate | TCGA BRCA -0.216; TCGA CESC -0.127; TCGA ESCA -0.119; TCGA HNSC -0.212; TCGA KIRP -0.106; TCGA LGG -0.059; TCGA LIHC -0.174; TCGA LUAD -0.278; TCGA LUSC -0.344; TCGA OV -0.092 |
hsa-let-7b-5p | FLAD1 | 11 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.246; TCGA HNSC -0.135; TCGA KIRC -0.083; TCGA KIRP -0.121; TCGA LGG -0.067; TCGA LIHC -0.15; TCGA LUAD -0.276; TCGA LUSC -0.297; TCGA OV -0.123; TCGA SARC -0.105; TCGA THCA -0.212 |
hsa-let-7b-5p | FOXRED1 | 11 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.167; TCGA HNSC -0.154; TCGA KIRC -0.376; TCGA KIRP -0.21; TCGA LGG -0.076; TCGA LIHC -0.101; TCGA LUAD -0.164; TCGA LUSC -0.286; TCGA PAAD -0.179; TCGA SARC -0.115; TCGA THCA -0.117 |
hsa-let-7b-5p | GEMIN7 | 10 cancers: BRCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.227; TCGA HNSC -0.259; TCGA KIRP -0.075; TCGA LIHC -0.215; TCGA LUAD -0.174; TCGA LUSC -0.279; TCGA OV -0.093; TCGA PAAD -0.194; TCGA THCA -0.074; TCGA UCEC -0.124 |
hsa-let-7b-5p | GGCT | 10 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; THCA | miRNAWalker2 validate | TCGA BRCA -0.28; TCGA COAD -0.144; TCGA HNSC -0.278; TCGA KIRC -0.255; TCGA KIRP -0.189; TCGA LGG -0.073; TCGA LIHC -0.137; TCGA LUAD -0.265; TCGA LUSC -0.446; TCGA THCA -0.462 |
hsa-let-7b-5p | GPI | 9 cancers: BRCA; KIRP; LGG; LIHC; LUAD; LUSC; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.191; TCGA KIRP -0.286; TCGA LGG -0.071; TCGA LIHC -0.076; TCGA LUAD -0.193; TCGA LUSC -0.407; TCGA SARC -0.161; TCGA THCA -0.335; TCGA UCEC -0.106 |
hsa-let-7b-5p | GTPBP3 | 14 cancers: BRCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.161; TCGA CESC -0.088; TCGA COAD -0.093; TCGA HNSC -0.279; TCGA KIRP -0.079; TCGA LGG -0.197; TCGA LIHC -0.139; TCGA LUAD -0.256; TCGA LUSC -0.454; TCGA OV -0.174; TCGA PAAD -0.332; TCGA SARC -0.133; TCGA THCA -0.128; TCGA UCEC -0.082 |
hsa-let-7b-5p | HARS | 11 cancers: BRCA; COAD; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BRCA -0.072; TCGA COAD -0.078; TCGA KIRP -0.096; TCGA LGG -0.058; TCGA LIHC -0.161; TCGA LUAD -0.054; TCGA LUSC -0.077; TCGA PAAD -0.197; TCGA SARC -0.125; TCGA THCA -0.051; TCGA STAD -0.106 |
hsa-let-7b-5p | HGS | 12 cancers: BRCA; CESC; COAD; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.18; TCGA CESC -0.071; TCGA COAD -0.086; TCGA HNSC -0.099; TCGA LGG -0.087; TCGA LIHC -0.271; TCGA LUAD -0.213; TCGA LUSC -0.253; TCGA OV -0.081; TCGA PAAD -0.212; TCGA SARC -0.066; TCGA THCA -0.201 |
hsa-let-7b-5p | HMGA1 | 11 cancers: BRCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PRAD; THCA; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | TCGA BRCA -0.456; TCGA HNSC -0.29; TCGA KIRC -0.408; TCGA LGG -0.093; TCGA LIHC -0.294; TCGA LUAD -0.416; TCGA LUSC -0.499; TCGA OV -0.186; TCGA PRAD -0.146; TCGA THCA -0.192; TCGA UCEC -0.434 |
hsa-let-7b-5p | IFRD1 | 9 cancers: BRCA; COAD; HNSC; LIHC; LUAD; LUSC; OV; PAAD; SARC | miRNAWalker2 validate | TCGA BRCA -0.188; TCGA COAD -0.205; TCGA HNSC -0.26; TCGA LIHC -0.116; TCGA LUAD -0.315; TCGA LUSC -0.224; TCGA OV -0.083; TCGA PAAD -0.171; TCGA SARC -0.313 |
hsa-let-7b-5p | IGF2BP1 | 11 cancers: BRCA; CESC; ESCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; SARC; UCEC | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP; RAID | TCGA BRCA -0.519; TCGA CESC -0.752; TCGA ESCA -0.979; TCGA HNSC -0.93; TCGA KIRC -0.524; TCGA LIHC -0.946; TCGA LUAD -1.237; TCGA LUSC -1.624; TCGA OV -1.005; TCGA SARC -0.65; TCGA UCEC -1.009 |
hsa-let-7b-5p | IGF2BP2 | 10 cancers: BRCA; CESC; COAD; HNSC; KIRC; LUAD; LUSC; OV; PRAD; UCEC | miRNAWalker2 validate; MirTarget; miRNATAP | TCGA BRCA -0.201; TCGA CESC -0.502; TCGA COAD -0.211; TCGA HNSC -0.263; TCGA KIRC -1.358; TCGA LUAD -0.231; TCGA LUSC -0.792; TCGA OV -0.376; TCGA PRAD -0.475; TCGA UCEC -0.983 |
hsa-let-7b-5p | IPO4 | 10 cancers: BRCA; CESC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.095; TCGA CESC -0.21; TCGA KIRP -0.143; TCGA LIHC -0.135; TCGA LUAD -0.284; TCGA LUSC -0.258; TCGA OV -0.12; TCGA PAAD -0.173; TCGA THCA -0.131; TCGA UCEC -0.122 |
hsa-let-7b-5p | LACTB2 | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.148; TCGA ESCA -0.559; TCGA HNSC -0.125; TCGA KIRC -0.275; TCGA KIRP -0.34; TCGA LIHC -0.149; TCGA LUAD -0.096; TCGA LUSC -0.201; TCGA SARC -0.26; TCGA THCA -0.371 |
hsa-let-7b-5p | MAP2K2 | 10 cancers: BRCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; THCA; STAD | miRNAWalker2 validate | TCGA BRCA -0.172; TCGA HNSC -0.227; TCGA KIRP -0.133; TCGA LGG -0.156; TCGA LIHC -0.179; TCGA LUAD -0.099; TCGA LUSC -0.122; TCGA PAAD -0.389; TCGA THCA -0.169; TCGA STAD -0.122 |
hsa-let-7b-5p | MARS | 13 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.172; TCGA CESC -0.098; TCGA HNSC -0.052; TCGA KIRC -0.167; TCGA KIRP -0.108; TCGA LGG -0.1; TCGA LIHC -0.149; TCGA LUAD -0.254; TCGA LUSC -0.256; TCGA OV -0.186; TCGA PAAD -0.232; TCGA THCA -0.12; TCGA UCEC -0.074 |
hsa-let-7b-5p | MED25 | 9 cancers: BRCA; COAD; HNSC; LGG; LIHC; LUSC; OV; PAAD; STAD | miRNAWalker2 validate | TCGA BRCA -0.122; TCGA COAD -0.087; TCGA HNSC -0.09; TCGA LGG -0.096; TCGA LIHC -0.084; TCGA LUSC -0.078; TCGA OV -0.172; TCGA PAAD -0.377; TCGA STAD -0.12 |
hsa-let-7b-5p | MFSD3 | 11 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD | miRNAWalker2 validate | TCGA BRCA -0.348; TCGA CESC -0.298; TCGA COAD -0.187; TCGA HNSC -0.265; TCGA KIRC -0.679; TCGA KIRP -0.309; TCGA LGG -0.228; TCGA LIHC -0.217; TCGA LUAD -0.218; TCGA LUSC -0.262; TCGA PAAD -0.474 |
hsa-let-7b-5p | MPND | 9 cancers: BRCA; COAD; HNSC; KIRP; LGG; LIHC; PAAD; THCA; STAD | miRNAWalker2 validate | TCGA BRCA -0.169; TCGA COAD -0.104; TCGA HNSC -0.264; TCGA KIRP -0.154; TCGA LGG -0.141; TCGA LIHC -0.105; TCGA PAAD -0.243; TCGA THCA -0.321; TCGA STAD -0.173 |
hsa-let-7b-5p | MRM1 | 11 cancers: BRCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.151; TCGA CESC -0.194; TCGA HNSC -0.37; TCGA KIRP -0.263; TCGA LGG -0.1; TCGA LIHC -0.259; TCGA LUAD -0.26; TCGA LUSC -0.441; TCGA PAAD -0.538; TCGA THCA -0.229; TCGA UCEC -0.112 |
hsa-let-7b-5p | MRPL47 | 12 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.201; TCGA COAD -0.104; TCGA HNSC -0.279; TCGA KIRC -0.221; TCGA KIRP -0.238; TCGA LGG -0.054; TCGA LIHC -0.14; TCGA LUAD -0.169; TCGA LUSC -0.42; TCGA SARC -0.144; TCGA THCA -0.068; TCGA UCEC -0.119 |
hsa-let-7b-5p | MRPS11 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LIHC; LUSC; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.152; TCGA HNSC -0.168; TCGA KIRC -0.144; TCGA KIRP -0.2; TCGA LIHC -0.151; TCGA LUSC -0.14; TCGA PAAD -0.145; TCGA SARC -0.11; TCGA THCA -0.103 |
hsa-let-7b-5p | MRPS24 | 12 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.252; TCGA COAD -0.143; TCGA HNSC -0.308; TCGA KIRC -0.193; TCGA KIRP -0.233; TCGA LGG -0.097; TCGA LIHC -0.201; TCGA LUAD -0.212; TCGA LUSC -0.247; TCGA PAAD -0.27; TCGA SARC -0.132; TCGA THCA -0.277 |
hsa-let-7b-5p | MRPS33 | 12 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.142; TCGA COAD -0.199; TCGA HNSC -0.204; TCGA KIRC -0.209; TCGA KIRP -0.233; TCGA LIHC -0.176; TCGA LUAD -0.132; TCGA LUSC -0.306; TCGA PAAD -0.277; TCGA SARC -0.13; TCGA THCA -0.165; TCGA UCEC -0.129 |
hsa-let-7b-5p | MSI1 | 9 cancers: BRCA; COAD; LGG; LUAD; LUSC; OV; PAAD; STAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.465; TCGA COAD -0.477; TCGA LGG -0.123; TCGA LUAD -0.555; TCGA LUSC -1.099; TCGA OV -0.493; TCGA PAAD -1; TCGA STAD -0.451; TCGA UCEC -0.231 |
hsa-let-7b-5p | NAA10 | 10 cancers: BRCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.289; TCGA HNSC -0.269; TCGA KIRP -0.12; TCGA LGG -0.141; TCGA LIHC -0.214; TCGA LUAD -0.21; TCGA LUSC -0.215; TCGA PAAD -0.219; TCGA SARC -0.156; TCGA THCA -0.205 |
hsa-let-7b-5p | NAA20 | 10 cancers: BRCA; COAD; KIRC; KIRP; LIHC; LUSC; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.121; TCGA COAD -0.149; TCGA KIRC -0.125; TCGA KIRP -0.095; TCGA LIHC -0.158; TCGA LUSC -0.119; TCGA PAAD -0.402; TCGA SARC -0.098; TCGA THCA -0.062; TCGA UCEC -0.078 |
hsa-let-7b-5p | NDUFA10 | 9 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; THCA | miRNAWalker2 validate | TCGA BRCA -0.056; TCGA COAD -0.099; TCGA HNSC -0.14; TCGA KIRC -0.338; TCGA KIRP -0.243; TCGA LIHC -0.063; TCGA LUAD -0.075; TCGA LUSC -0.138; TCGA THCA -0.165 |
hsa-let-7b-5p | NME4 | 10 cancers: BRCA; COAD; KIRP; LGG; LUAD; LUSC; PAAD; SARC; THCA; STAD | miRNAWalker2 validate; MirTarget; miRNATAP | TCGA BRCA -0.199; TCGA COAD -0.184; TCGA KIRP -0.114; TCGA LGG -0.088; TCGA LUAD -0.177; TCGA LUSC -0.251; TCGA PAAD -0.198; TCGA SARC -0.267; TCGA THCA -0.07; TCGA STAD -0.428 |
hsa-let-7b-5p | NME6 | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; OV; THCA; UCEC | miRNAWalker2 validate; MirTarget; miRNATAP | TCGA BRCA -0.095; TCGA ESCA -0.131; TCGA HNSC -0.065; TCGA KIRC -0.335; TCGA KIRP -0.157; TCGA LIHC -0.265; TCGA LUAD -0.088; TCGA OV -0.073; TCGA THCA -0.186; TCGA UCEC -0.109 |
hsa-let-7b-5p | NUBP2 | 10 cancers: BRCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.253; TCGA HNSC -0.175; TCGA KIRP -0.139; TCGA LGG -0.131; TCGA LIHC -0.155; TCGA LUAD -0.087; TCGA LUSC -0.1; TCGA PAAD -0.351; TCGA SARC -0.081; TCGA THCA -0.115 |
hsa-let-7b-5p | OTUB1 | 14 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.164; TCGA CESC -0.102; TCGA COAD -0.078; TCGA HNSC -0.146; TCGA KIRC -0.123; TCGA KIRP -0.065; TCGA LGG -0.118; TCGA LIHC -0.123; TCGA LUAD -0.085; TCGA LUSC -0.135; TCGA PAAD -0.117; TCGA SARC -0.107; TCGA THCA -0.071; TCGA UCEC -0.072 |
hsa-let-7b-5p | PCYT2 | 10 cancers: BRCA; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUSC; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.139; TCGA ESCA -0.205; TCGA HNSC -0.234; TCGA KIRC -0.675; TCGA KIRP -0.333; TCGA LGG -0.07; TCGA LIHC -0.261; TCGA LUSC -0.197; TCGA SARC -0.131; TCGA THCA -0.215 |
hsa-let-7b-5p | PDCL3 | 11 cancers: BRCA; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; OV; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.165; TCGA COAD -0.094; TCGA HNSC -0.174; TCGA KIRP -0.159; TCGA LIHC -0.094; TCGA LUAD -0.146; TCGA LUSC -0.187; TCGA OV -0.076; TCGA SARC -0.144; TCGA THCA -0.057; TCGA UCEC -0.083 |
hsa-let-7b-5p | PDHX | 9 cancers: BRCA; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.054; TCGA ESCA -0.121; TCGA KIRC -0.269; TCGA KIRP -0.175; TCGA LIHC -0.058; TCGA LUAD -0.062; TCGA LUSC -0.155; TCGA SARC -0.107; TCGA THCA -0.119 |
hsa-let-7b-5p | PIGU | 11 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; UCEC | miRNAWalker2 validate | TCGA BRCA -0.192; TCGA COAD -0.274; TCGA HNSC -0.222; TCGA KIRC -0.152; TCGA KIRP -0.059; TCGA LIHC -0.243; TCGA LUAD -0.156; TCGA LUSC -0.27; TCGA OV -0.177; TCGA PAAD -0.206; TCGA UCEC -0.075 |
hsa-let-7b-5p | PLAGL2 | 9 cancers: BRCA; CESC; COAD; ESCA; LUSC; OV; PAAD; STAD; UCEC | miRNAWalker2 validate; MirTarget; miRNATAP | TCGA BRCA -0.105; TCGA CESC -0.171; TCGA COAD -0.293; TCGA ESCA -0.186; TCGA LUSC -0.288; TCGA OV -0.294; TCGA PAAD -0.178; TCGA STAD -0.205; TCGA UCEC -0.249 |
hsa-let-7b-5p | POLR2H | 9 cancers: BRCA; COAD; HNSC; LGG; LIHC; LUAD; LUSC; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.223; TCGA COAD -0.11; TCGA HNSC -0.406; TCGA LGG -0.093; TCGA LIHC -0.186; TCGA LUAD -0.242; TCGA LUSC -0.491; TCGA SARC -0.104; TCGA THCA -0.073 |
hsa-let-7b-5p | PPID | 11 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.069; TCGA HNSC -0.111; TCGA KIRC -0.127; TCGA KIRP -0.137; TCGA LGG -0.051; TCGA LIHC -0.063; TCGA LUAD -0.085; TCGA LUSC -0.102; TCGA OV -0.066; TCGA PAAD -0.135; TCGA THCA -0.081 |
hsa-let-7b-5p | PSMG4 | 10 cancers: BRCA; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC | miRNAWalker2 validate | TCGA BRCA -0.232; TCGA COAD -0.175; TCGA HNSC -0.374; TCGA KIRP -0.127; TCGA LGG -0.1; TCGA LIHC -0.305; TCGA LUAD -0.107; TCGA LUSC -0.202; TCGA PAAD -0.312; TCGA SARC -0.174 |
hsa-let-7b-5p | PTCD1 | 10 cancers: BRCA; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.168; TCGA COAD -0.11; TCGA KIRC -0.099; TCGA KIRP -0.113; TCGA LIHC -0.14; TCGA LUAD -0.22; TCGA LUSC -0.324; TCGA OV -0.082; TCGA PAAD -0.207; TCGA THCA -0.182 |
hsa-let-7b-5p | PTGES2 | 11 cancers: BRCA; CESC; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.251; TCGA CESC -0.159; TCGA HNSC -0.234; TCGA KIRC -0.295; TCGA KIRP -0.238; TCGA LGG -0.165; TCGA LIHC -0.192; TCGA LUAD -0.198; TCGA LUSC -0.302; TCGA PAAD -0.379; TCGA THCA -0.182 |
hsa-let-7b-5p | PUS1 | 11 cancers: BRCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.33; TCGA CESC -0.124; TCGA HNSC -0.311; TCGA KIRP -0.17; TCGA LGG -0.143; TCGA LIHC -0.246; TCGA LUAD -0.366; TCGA LUSC -0.42; TCGA OV -0.108; TCGA PAAD -0.263; TCGA THCA -0.101 |
hsa-let-7b-5p | QRSL1 | 10 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUSC; OV; THCA | miRNAWalker2 validate | TCGA BRCA -0.104; TCGA CESC -0.1; TCGA COAD -0.171; TCGA ESCA -0.133; TCGA KIRC -0.292; TCGA KIRP -0.198; TCGA LIHC -0.053; TCGA LUSC -0.15; TCGA OV -0.115; TCGA THCA -0.082 |
hsa-let-7b-5p | RBM19 | 12 cancers: BRCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.097; TCGA CESC -0.112; TCGA COAD -0.099; TCGA HNSC -0.097; TCGA KIRP -0.097; TCGA LIHC -0.192; TCGA LUAD -0.194; TCGA LUSC -0.305; TCGA OV -0.144; TCGA PAAD -0.224; TCGA THCA -0.121; TCGA UCEC -0.081 |
hsa-let-7b-5p | REPS1 | 9 cancers: BRCA; COAD; KIRC; KIRP; LGG; LUAD; LUSC; OV; PAAD | miRNAWalker2 validate | TCGA BRCA -0.055; TCGA COAD -0.081; TCGA KIRC -0.088; TCGA KIRP -0.068; TCGA LGG -0.071; TCGA LUAD -0.087; TCGA LUSC -0.183; TCGA OV -0.241; TCGA PAAD -0.175 |
hsa-let-7b-5p | SLC25A1 | 9 cancers: BRCA; HNSC; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.139; TCGA HNSC -0.115; TCGA LGG -0.14; TCGA LIHC -0.123; TCGA LUAD -0.072; TCGA LUSC -0.146; TCGA PAAD -0.202; TCGA SARC -0.098; TCGA THCA -0.09 |
hsa-let-7b-5p | SLC25A13 | 11 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; OV; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.195; TCGA CESC -0.13; TCGA COAD -0.118; TCGA ESCA -0.232; TCGA KIRC -0.216; TCGA KIRP -0.143; TCGA LUAD -0.209; TCGA LUSC -0.304; TCGA OV -0.207; TCGA THCA -0.188; TCGA UCEC -0.075 |
hsa-let-7b-5p | SLC25A19 | 9 cancers: BRCA; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.281; TCGA ESCA -0.194; TCGA HNSC -0.31; TCGA KIRP -0.174; TCGA LIHC -0.223; TCGA LUAD -0.151; TCGA LUSC -0.203; TCGA SARC -0.131; TCGA THCA -0.21 |
hsa-let-7b-5p | SMARCA4 | 10 cancers: BRCA; CESC; KIRC; KIRP; LGG; LIHC; LUSC; OV; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.172; TCGA CESC -0.1; TCGA KIRC -0.145; TCGA KIRP -0.055; TCGA LGG -0.124; TCGA LIHC -0.061; TCGA LUSC -0.151; TCGA OV -0.214; TCGA PAAD -0.132; TCGA THCA -0.196 |
hsa-let-7b-5p | SNRPA | 10 cancers: BRCA; COAD; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC | miRNAWalker2 validate | TCGA BRCA -0.183; TCGA COAD -0.122; TCGA HNSC -0.224; TCGA LGG -0.084; TCGA LIHC -0.218; TCGA LUAD -0.169; TCGA LUSC -0.326; TCGA OV -0.055; TCGA PAAD -0.158; TCGA SARC -0.076 |
hsa-let-7b-5p | SPRYD4 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LUAD; LUSC; PAAD; THCA; UCEC | miRNAWalker2 validate; MirTarget | TCGA BRCA -0.097; TCGA HNSC -0.099; TCGA KIRC -0.379; TCGA KIRP -0.211; TCGA LUAD -0.067; TCGA LUSC -0.285; TCGA PAAD -0.275; TCGA THCA -0.083; TCGA UCEC -0.102 |
hsa-let-7b-5p | STIP1 | 9 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; SARC; UCEC | miRNAWalker2 validate | TCGA BRCA -0.202; TCGA CESC -0.107; TCGA HNSC -0.114; TCGA KIRP -0.099; TCGA LIHC -0.196; TCGA LUAD -0.211; TCGA LUSC -0.209; TCGA SARC -0.139; TCGA UCEC -0.063 |
hsa-let-7b-5p | STK38 | 10 cancers: BRCA; COAD; ESCA; HNSC; LUAD; LUSC; OV; PRAD; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.159; TCGA COAD -0.179; TCGA ESCA -0.125; TCGA HNSC -0.103; TCGA LUAD -0.053; TCGA LUSC -0.107; TCGA OV -0.064; TCGA PRAD -0.129; TCGA THCA -0.118; TCGA UCEC -0.073 |
hsa-let-7b-5p | TBRG4 | 14 cancers: BRCA; CESC; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.283; TCGA CESC -0.136; TCGA COAD -0.172; TCGA HNSC -0.165; TCGA KIRC -0.111; TCGA KIRP -0.226; TCGA LIHC -0.2; TCGA LUAD -0.257; TCGA LUSC -0.354; TCGA OV -0.12; TCGA PAAD -0.18; TCGA SARC -0.089; TCGA THCA -0.254; TCGA UCEC -0.081 |
hsa-let-7b-5p | TCOF1 | 9 cancers: BRCA; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.214; TCGA LIHC -0.249; TCGA LUAD -0.201; TCGA LUSC -0.31; TCGA OV -0.079; TCGA PAAD -0.166; TCGA SARC -0.205; TCGA THCA -0.133; TCGA UCEC -0.115 |
hsa-let-7b-5p | TIMM50 | 13 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.25; TCGA COAD -0.105; TCGA HNSC -0.212; TCGA KIRC -0.085; TCGA KIRP -0.225; TCGA LGG -0.074; TCGA LIHC -0.225; TCGA LUAD -0.157; TCGA LUSC -0.36; TCGA OV -0.159; TCGA SARC -0.091; TCGA THCA -0.212; TCGA UCEC -0.156 |
hsa-let-7b-5p | TIMM8A | 9 cancers: BRCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.227; TCGA HNSC -0.272; TCGA KIRC -0.198; TCGA KIRP -0.251; TCGA LIHC -0.337; TCGA LUAD -0.249; TCGA LUSC -0.43; TCGA THCA -0.225; TCGA UCEC -0.184 |
hsa-let-7b-5p | TMEM55B | 13 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.084; TCGA HNSC -0.113; TCGA KIRC -0.207; TCGA KIRP -0.076; TCGA LGG -0.069; TCGA LIHC -0.08; TCGA LUAD -0.064; TCGA LUSC -0.082; TCGA OV -0.071; TCGA PAAD -0.186; TCGA SARC -0.084; TCGA THCA -0.131; TCGA UCEC -0.066 |
hsa-let-7b-5p | TRAPPC1 | 9 cancers: BRCA; HNSC; KIRP; LGG; LIHC; PAAD; PRAD; THCA; STAD | miRNAWalker2 validate | TCGA BRCA -0.152; TCGA HNSC -0.177; TCGA KIRP -0.139; TCGA LGG -0.07; TCGA LIHC -0.161; TCGA PAAD -0.295; TCGA PRAD -0.15; TCGA THCA -0.089; TCGA STAD -0.168 |
hsa-let-7b-5p | TRIM28 | 9 cancers: BRCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.108; TCGA HNSC -0.14; TCGA LGG -0.065; TCGA LIHC -0.165; TCGA LUAD -0.163; TCGA LUSC -0.235; TCGA OV -0.1; TCGA PAAD -0.118; TCGA THCA -0.052 |
hsa-let-7b-5p | TRMT1 | 12 cancers: BRCA; CESC; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.178; TCGA CESC -0.107; TCGA COAD -0.186; TCGA HNSC -0.292; TCGA KIRP -0.123; TCGA LGG -0.155; TCGA LIHC -0.236; TCGA LUAD -0.218; TCGA LUSC -0.362; TCGA OV -0.101; TCGA PAAD -0.371; TCGA THCA -0.148 |
hsa-let-7b-5p | TRUB2 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.07; TCGA HNSC -0.099; TCGA KIRC -0.264; TCGA KIRP -0.225; TCGA LIHC -0.119; TCGA LUAD -0.066; TCGA LUSC -0.202; TCGA PAAD -0.149; TCGA THCA -0.13 |
hsa-let-7b-5p | TTC9C | 9 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.116; TCGA CESC -0.097; TCGA HNSC -0.109; TCGA KIRP -0.118; TCGA LIHC -0.084; TCGA LUAD -0.062; TCGA LUSC -0.109; TCGA THCA -0.091; TCGA UCEC -0.098 |
hsa-let-7b-5p | TXNL4A | 9 cancers: BRCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.176; TCGA HNSC -0.212; TCGA KIRP -0.196; TCGA LGG -0.09; TCGA LIHC -0.191; TCGA LUAD -0.105; TCGA LUSC -0.149; TCGA PAAD -0.3; TCGA THCA -0.149 |
hsa-let-7b-5p | TYMS | 9 cancers: BRCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.352; TCGA HNSC -0.224; TCGA KIRP -0.156; TCGA LIHC -0.288; TCGA LUAD -0.424; TCGA LUSC -0.526; TCGA OV -0.177; TCGA THCA -0.56; TCGA UCEC -0.146 |
hsa-let-7b-5p | UBE2D2 | 9 cancers: BRCA; COAD; HNSC; KIRP; LIHC; LUSC; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA BRCA -0.076; TCGA COAD -0.081; TCGA HNSC -0.057; TCGA KIRP -0.074; TCGA LIHC -0.113; TCGA LUSC -0.078; TCGA PAAD -0.09; TCGA SARC -0.063; TCGA THCA -0.054 |
hsa-let-7b-5p | UBE2M | 9 cancers: BRCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; THCA | miRNAWalker2 validate | TCGA BRCA -0.212; TCGA HNSC -0.238; TCGA KIRP -0.166; TCGA LGG -0.12; TCGA LIHC -0.193; TCGA LUAD -0.158; TCGA LUSC -0.181; TCGA PAAD -0.37; TCGA THCA -0.171 |
hsa-let-7b-5p | UCK1 | 9 cancers: BRCA; HNSC; KIRP; LGG; LIHC; PAAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA BRCA -0.068; TCGA HNSC -0.085; TCGA KIRP -0.074; TCGA LGG -0.098; TCGA LIHC -0.097; TCGA PAAD -0.34; TCGA SARC -0.111; TCGA THCA -0.066; TCGA STAD -0.164 |
hsa-let-7b-5p | UTP6 | 10 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; OV; SARC; UCEC | miRNAWalker2 validate | TCGA BRCA -0.106; TCGA CESC -0.064; TCGA HNSC -0.14; TCGA KIRP -0.071; TCGA LIHC -0.17; TCGA LUAD -0.164; TCGA LUSC -0.245; TCGA OV -0.072; TCGA SARC -0.118; TCGA UCEC -0.112 |
hsa-let-7b-5p | WDR74 | 11 cancers: BRCA; COAD; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; SARC; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.205; TCGA COAD -0.14; TCGA HNSC -0.274; TCGA KIRP -0.097; TCGA LGG -0.12; TCGA LIHC -0.17; TCGA LUAD -0.165; TCGA LUSC -0.256; TCGA SARC -0.175; TCGA THCA -0.073; TCGA UCEC -0.098 |
hsa-let-7b-5p | XPO5 | 11 cancers: BRCA; CESC; COAD; KIRC; KIRP; LIHC; LUAD; LUSC; OV; THCA; UCEC | miRNAWalker2 validate | TCGA BRCA -0.18; TCGA CESC -0.174; TCGA COAD -0.122; TCGA KIRC -0.092; TCGA KIRP -0.133; TCGA LIHC -0.209; TCGA LUAD -0.235; TCGA LUSC -0.279; TCGA OV -0.256; TCGA THCA -0.08; TCGA UCEC -0.161 |
hsa-let-7b-5p | ZCCHC9 | 10 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; SARC; UCEC | miRNAWalker2 validate | TCGA BRCA -0.073; TCGA COAD -0.103; TCGA HNSC -0.074; TCGA KIRC -0.139; TCGA KIRP -0.07; TCGA LIHC -0.246; TCGA LUAD -0.077; TCGA LUSC -0.198; TCGA SARC -0.128; TCGA UCEC -0.1 |
hsa-let-7b-5p | AP1S1 | 10 cancers: BRCA; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.296; TCGA COAD -0.149; TCGA HNSC -0.107; TCGA KIRP -0.242; TCGA LIHC -0.165; TCGA LUAD -0.076; TCGA LUSC -0.231; TCGA PAAD -0.21; TCGA THCA -0.248; TCGA UCEC -0.069 |
hsa-let-7b-5p | LIPT2 | 9 cancers: BRCA; HNSC; KIRC; LIHC; LUAD; LUSC; OV; PAAD; SARC | MirTarget; miRNATAP | TCGA BRCA -0.128; TCGA HNSC -0.204; TCGA KIRC -0.112; TCGA LIHC -0.125; TCGA LUAD -0.137; TCGA LUSC -0.367; TCGA OV -0.215; TCGA PAAD -0.184; TCGA SARC -0.109 |
hsa-let-7b-5p | DCAF15 | 11 cancers: BRCA; COAD; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.173; TCGA COAD -0.078; TCGA HNSC -0.12; TCGA LGG -0.109; TCGA LIHC -0.086; TCGA LUAD -0.173; TCGA LUSC -0.214; TCGA OV -0.21; TCGA PAAD -0.252; TCGA THCA -0.056; TCGA UCEC -0.121 |
hsa-let-7b-5p | PARS2 | 9 cancers: BRCA; KIRC; KIRP; LIHC; LUAD; LUSC; OV; THCA; UCEC | MirTarget | TCGA BRCA -0.08; TCGA KIRC -0.216; TCGA KIRP -0.142; TCGA LIHC -0.181; TCGA LUAD -0.113; TCGA LUSC -0.172; TCGA OV -0.142; TCGA THCA -0.15; TCGA UCEC -0.134 |
hsa-let-7b-5p | SLC5A6 | 11 cancers: BRCA; CESC; COAD; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.286; TCGA CESC -0.145; TCGA COAD -0.306; TCGA HNSC -0.087; TCGA KIRC -0.21; TCGA LGG -0.07; TCGA LIHC -0.197; TCGA LUAD -0.233; TCGA LUSC -0.384; TCGA OV -0.265; TCGA UCEC -0.155 |
hsa-let-7b-5p | RNF5 | 10 cancers: BRCA; COAD; ESCA; HNSC; KIRP; LIHC; OV; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.094; TCGA COAD -0.153; TCGA ESCA -0.17; TCGA HNSC -0.223; TCGA KIRP -0.182; TCGA LIHC -0.136; TCGA OV -0.086; TCGA THCA -0.115; TCGA STAD -0.156; TCGA UCEC -0.083 |
hsa-let-7b-5p | FBXL12 | 9 cancers: BRCA; COAD; HNSC; LGG; LIHC; LUSC; OV; PAAD; STAD | MirTarget; miRNATAP | TCGA BRCA -0.062; TCGA COAD -0.11; TCGA HNSC -0.057; TCGA LGG -0.069; TCGA LIHC -0.095; TCGA LUSC -0.092; TCGA OV -0.145; TCGA PAAD -0.092; TCGA STAD -0.088 |
hsa-let-7b-5p | RPUSD3 | 12 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; UCEC | MirTarget | TCGA BRCA -0.249; TCGA HNSC -0.225; TCGA KIRC -0.315; TCGA KIRP -0.197; TCGA LGG -0.083; TCGA LIHC -0.257; TCGA LUAD -0.113; TCGA LUSC -0.27; TCGA PAAD -0.215; TCGA SARC -0.153; TCGA THCA -0.154; TCGA UCEC -0.063 |
hsa-let-7b-5p | CELF3 | 9 cancers: BRCA; COAD; ESCA; LGG; LUAD; OV; PAAD; SARC; STAD | MirTarget | TCGA BRCA -0.324; TCGA COAD -0.783; TCGA ESCA -1.184; TCGA LGG -0.249; TCGA LUAD -0.81; TCGA OV -0.939; TCGA PAAD -1.292; TCGA SARC -0.644; TCGA STAD -0.753 |
hsa-let-7b-5p | RPUSD2 | 10 cancers: BRCA; HNSC; KIRP; LGG; LIHC; LUSC; OV; PAAD; SARC; THCA | MirTarget; miRNATAP | TCGA BRCA -0.088; TCGA HNSC -0.112; TCGA KIRP -0.102; TCGA LGG -0.066; TCGA LIHC -0.138; TCGA LUSC -0.161; TCGA OV -0.077; TCGA PAAD -0.223; TCGA SARC -0.103; TCGA THCA -0.069 |
hsa-let-7b-5p | ABCC10 | 9 cancers: BRCA; CESC; COAD; KIRC; LGG; LIHC; LUAD; LUSC; OV | MirTarget; miRNATAP | TCGA BRCA -0.17; TCGA CESC -0.134; TCGA COAD -0.128; TCGA KIRC -0.11; TCGA LGG -0.084; TCGA LIHC -0.089; TCGA LUAD -0.2; TCGA LUSC -0.24; TCGA OV -0.209 |
hsa-let-7b-5p | STX3 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRP; SARC; THCA; UCEC | MirTarget | TCGA BRCA -0.098; TCGA CESC -0.172; TCGA COAD -0.161; TCGA ESCA -0.43; TCGA HNSC -0.084; TCGA KIRP -0.249; TCGA SARC -0.396; TCGA THCA -0.305; TCGA UCEC -0.156 |
hsa-let-7b-5p | GNG5 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LIHC; PRAD; SARC; THCA; UCEC | MirTarget; miRNATAP | TCGA BRCA -0.215; TCGA HNSC -0.136; TCGA KIRC -0.074; TCGA KIRP -0.115; TCGA LIHC -0.066; TCGA PRAD -0.075; TCGA SARC -0.128; TCGA THCA -0.138; TCGA UCEC -0.129 |
hsa-let-7b-5p | TMEM104 | 9 cancers: BRCA; CESC; KIRC; KIRP; LIHC; LUAD; OV; PAAD; UCEC | mirMAP | TCGA BRCA -0.16; TCGA CESC -0.14; TCGA KIRC -0.212; TCGA KIRP -0.104; TCGA LIHC -0.201; TCGA LUAD -0.096; TCGA OV -0.085; TCGA PAAD -0.285; TCGA UCEC -0.115 |
hsa-let-7b-5p | DDA1 | 9 cancers: BRCA; HNSC; LGG; LIHC; LUSC; OV; PAAD; SARC; THCA | mirMAP | TCGA BRCA -0.149; TCGA HNSC -0.158; TCGA LGG -0.084; TCGA LIHC -0.15; TCGA LUSC -0.11; TCGA OV -0.091; TCGA PAAD -0.198; TCGA SARC -0.179; TCGA THCA -0.192 |
hsa-let-7b-5p | LRPAP1 | 9 cancers: BRCA; HNSC; KIRC; KIRP; LGG; LIHC; PAAD; THCA; UCEC | mirMAP | TCGA BRCA -0.072; TCGA HNSC -0.084; TCGA KIRC -0.153; TCGA KIRP -0.136; TCGA LGG -0.056; TCGA LIHC -0.088; TCGA PAAD -0.419; TCGA THCA -0.124; TCGA UCEC -0.09 |
hsa-let-7b-5p | SOX12 | 12 cancers: BRCA; CESC; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; STAD; UCEC | mirMAP | TCGA BRCA -0.175; TCGA CESC -0.222; TCGA HNSC -0.187; TCGA KIRP -0.202; TCGA LGG -0.178; TCGA LIHC -0.269; TCGA LUAD -0.289; TCGA LUSC -0.481; TCGA OV -0.165; TCGA PAAD -0.472; TCGA STAD -0.248; TCGA UCEC -0.207 |
hsa-let-7b-5p | BRI3BP | 9 cancers: BRCA; CESC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; THCA | mirMAP | TCGA BRCA -0.164; TCGA CESC -0.127; TCGA KIRC -0.231; TCGA KIRP -0.106; TCGA LIHC -0.158; TCGA LUAD -0.294; TCGA LUSC -0.327; TCGA OV -0.101; TCGA THCA -0.089 |
hsa-let-7b-5p | CLCN5 | 10 cancers: BRCA; CESC; ESCA; KIRC; KIRP; LUSC; OV; PAAD; THCA; UCEC | miRNATAP | TCGA BRCA -0.224; TCGA CESC -0.144; TCGA ESCA -0.295; TCGA KIRC -0.621; TCGA KIRP -0.155; TCGA LUSC -0.138; TCGA OV -0.138; TCGA PAAD -0.335; TCGA THCA -0.154; TCGA UCEC -0.107 |
hsa-let-7b-5p | AIFM1 | 13 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA | miRNATAP | TCGA BRCA -0.196; TCGA CESC -0.161; TCGA ESCA -0.191; TCGA HNSC -0.162; TCGA KIRC -0.471; TCGA KIRP -0.432; TCGA LGG -0.067; TCGA LIHC -0.089; TCGA LUAD -0.124; TCGA LUSC -0.241; TCGA PAAD -0.144; TCGA SARC -0.095; TCGA THCA -0.171 |
hsa-let-7b-5p | SENP5 | 10 cancers: BRCA; COAD; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; UCEC | miRNATAP | TCGA BRCA -0.076; TCGA COAD -0.088; TCGA LGG -0.052; TCGA LIHC -0.064; TCGA LUAD -0.124; TCGA LUSC -0.263; TCGA OV -0.086; TCGA PAAD -0.147; TCGA SARC -0.104; TCGA UCEC -0.141 |
hsa-let-7b-5p | CBX2 | 9 cancers: BRCA; CESC; LGG; LIHC; LUAD; LUSC; OV; THCA; UCEC | miRNATAP | TCGA BRCA -0.708; TCGA CESC -0.303; TCGA LGG -0.185; TCGA LIHC -0.286; TCGA LUAD -0.516; TCGA LUSC -0.625; TCGA OV -0.541; TCGA THCA -0.108; TCGA UCEC -0.172 |
hsa-let-7b-5p | ABCC5 | 11 cancers: BRCA; COAD; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD; UCEC | miRNATAP | TCGA BRCA -0.089; TCGA COAD -0.123; TCGA HNSC -0.283; TCGA KIRC -0.447; TCGA LGG -0.116; TCGA LIHC -0.203; TCGA LUAD -0.178; TCGA LUSC -0.714; TCGA OV -0.107; TCGA PAAD -0.256; TCGA UCEC -0.113 |
hsa-let-7b-5p | RAB15 | 12 cancers: BRCA; CESC; COAD; ESCA; KIRC; KIRP; LIHC; LUAD; LUSC; PAAD; THCA; STAD | miRNATAP | TCGA BRCA -0.13; TCGA CESC -0.225; TCGA COAD -0.168; TCGA ESCA -0.533; TCGA KIRC -0.55; TCGA KIRP -0.129; TCGA LIHC -0.151; TCGA LUAD -0.35; TCGA LUSC -0.196; TCGA PAAD -0.193; TCGA THCA -0.095; TCGA STAD -0.227 |
hsa-let-7b-5p | PCBP4 | 10 cancers: BRCA; COAD; HNSC; KIRC; LGG; LIHC; LUAD; PAAD; SARC; STAD | miRNATAP | TCGA BRCA -0.186; TCGA COAD -0.136; TCGA HNSC -0.137; TCGA KIRC -0.318; TCGA LGG -0.124; TCGA LIHC -0.208; TCGA LUAD -0.14; TCGA PAAD -0.26; TCGA SARC -0.12; TCGA STAD -0.162 |
hsa-let-7b-5p | RNF44 | 9 cancers: BRCA; CESC; COAD; KIRP; LGG; LIHC; LUSC; STAD; UCEC | miRNATAP | TCGA BRCA -0.077; TCGA CESC -0.164; TCGA COAD -0.194; TCGA KIRP -0.076; TCGA LGG -0.055; TCGA LIHC -0.097; TCGA LUSC -0.135; TCGA STAD -0.098; TCGA UCEC -0.092 |
hsa-let-7b-5p | ATXN7L2 | 9 cancers: BRCA; COAD; HNSC; LGG; LIHC; LUAD; LUSC; OV; PAAD | miRNATAP | TCGA BRCA -0.168; TCGA COAD -0.113; TCGA HNSC -0.185; TCGA LGG -0.235; TCGA LIHC -0.188; TCGA LUAD -0.198; TCGA LUSC -0.242; TCGA OV -0.203; TCGA PAAD -0.298 |
hsa-let-7b-5p | PNKD | 9 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; PRAD; UCEC | miRNATAP | TCGA BRCA -0.285; TCGA CESC -0.17; TCGA ESCA -0.551; TCGA HNSC -0.26; TCGA KIRC -0.511; TCGA KIRP -0.179; TCGA LGG -0.081; TCGA PRAD -0.153; TCGA UCEC -0.183 |
hsa-let-7b-5p | TEAD3 | 9 cancers: BRCA; COAD; KIRC; LIHC; OV; PRAD; SARC; STAD; UCEC | miRNATAP | TCGA BRCA -0.125; TCGA COAD -0.168; TCGA KIRC -0.111; TCGA LIHC -0.066; TCGA OV -0.153; TCGA PRAD -0.154; TCGA SARC -0.387; TCGA STAD -0.224; TCGA UCEC -0.071 |
hsa-let-7b-5p | PBX2 | 11 cancers: BRCA; COAD; HNSC; LGG; LIHC; LUAD; OV; PAAD; PRAD; STAD; UCEC | miRNATAP | TCGA BRCA -0.096; TCGA COAD -0.229; TCGA HNSC -0.11; TCGA LGG -0.055; TCGA LIHC -0.12; TCGA LUAD -0.054; TCGA OV -0.308; TCGA PAAD -0.118; TCGA PRAD -0.065; TCGA STAD -0.124; TCGA UCEC -0.213 |
hsa-let-7b-5p | NKIRAS2 | 9 cancers: BRCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; STAD; UCEC | miRNATAP | TCGA BRCA -0.143; TCGA HNSC -0.058; TCGA LGG -0.075; TCGA LIHC -0.188; TCGA LUAD -0.153; TCGA LUSC -0.197; TCGA OV -0.139; TCGA STAD -0.138; TCGA UCEC -0.082 |
hsa-let-7b-5p | FBXL19 | 9 cancers: BRCA; COAD; HNSC; LGG; LIHC; LUAD; LUSC; OV; UCEC | miRNATAP | TCGA BRCA -0.216; TCGA COAD -0.117; TCGA HNSC -0.079; TCGA LGG -0.188; TCGA LIHC -0.117; TCGA LUAD -0.297; TCGA LUSC -0.328; TCGA OV -0.128; TCGA UCEC -0.106 |
hsa-let-7b-5p | GPATCH3 | 9 cancers: BRCA; HNSC; KIRP; LGG; LIHC; OV; PAAD; THCA; UCEC | miRNATAP | TCGA BRCA -0.054; TCGA HNSC -0.134; TCGA KIRP -0.072; TCGA LGG -0.089; TCGA LIHC -0.219; TCGA OV -0.116; TCGA PAAD -0.207; TCGA THCA -0.114; TCGA UCEC -0.065 |
hsa-let-7b-5p | TIMM17B | 15 cancers: BRCA; COAD; HNSC; KIRC; KIRP; LGG; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | miRNATAP | TCGA BRCA -0.349; TCGA COAD -0.166; TCGA HNSC -0.321; TCGA KIRC -0.13; TCGA KIRP -0.11; TCGA LGG -0.113; TCGA LIHC -0.258; TCGA LUAD -0.267; TCGA LUSC -0.309; TCGA OV -0.104; TCGA PAAD -0.384; TCGA SARC -0.25; TCGA THCA -0.087; TCGA STAD -0.149; TCGA UCEC -0.135 |
hsa-let-7b-5p | EZH2 | 9 cancers: BRCA; HNSC; LIHC; LUAD; LUSC; OV; SARC; THCA; UCEC | miRNATAP | TCGA BRCA -0.439; TCGA HNSC -0.16; TCGA LIHC -0.273; TCGA LUAD -0.558; TCGA LUSC -0.7; TCGA OV -0.191; TCGA SARC -0.334; TCGA THCA -0.322; TCGA UCEC -0.117 |
hsa-let-7b-5p | CS | 10 cancers: CESC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA CESC -0.152; TCGA KIRC -0.247; TCGA KIRP -0.278; TCGA LIHC -0.123; TCGA LUAD -0.112; TCGA LUSC -0.103; TCGA OV -0.075; TCGA PAAD -0.131; TCGA SARC -0.083; TCGA THCA -0.226 |
hsa-let-7b-5p | GFM2 | 9 cancers: CESC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; THCA | miRNAWalker2 validate | TCGA CESC -0.102; TCGA KIRC -0.276; TCGA KIRP -0.191; TCGA LIHC -0.127; TCGA LUAD -0.05; TCGA LUSC -0.19; TCGA OV -0.131; TCGA PAAD -0.175; TCGA THCA -0.082 |
hsa-let-7b-5p | IGHMBP2 | 9 cancers: CESC; COAD; HNSC; LGG; LUAD; LUSC; PAAD; SARC; THCA | miRNAWalker2 validate | TCGA CESC -0.093; TCGA COAD -0.092; TCGA HNSC -0.112; TCGA LGG -0.09; TCGA LUAD -0.188; TCGA LUSC -0.223; TCGA PAAD -0.226; TCGA SARC -0.128; TCGA THCA -0.078 |
hsa-let-7b-5p | NAA40 | 10 cancers: CESC; ESCA; HNSC; KIRC; LGG; LIHC; LUAD; LUSC; OV; PAAD | miRNAWalker2 validate | TCGA CESC -0.116; TCGA ESCA -0.114; TCGA HNSC -0.142; TCGA KIRC -0.223; TCGA LGG -0.095; TCGA LIHC -0.094; TCGA LUAD -0.227; TCGA LUSC -0.311; TCGA OV -0.107; TCGA PAAD -0.171 |
hsa-let-7b-5p | NARS2 | 9 cancers: CESC; COAD; KIRC; KIRP; LIHC; LUAD; OV; THCA; UCEC | miRNAWalker2 validate | TCGA CESC -0.114; TCGA COAD -0.118; TCGA KIRC -0.301; TCGA KIRP -0.127; TCGA LIHC -0.074; TCGA LUAD -0.078; TCGA OV -0.122; TCGA THCA -0.063; TCGA UCEC -0.093 |
hsa-let-7b-5p | NLK | 12 cancers: CESC; COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; UCEC | miRNATAP | TCGA CESC -0.114; TCGA COAD -0.13; TCGA ESCA -0.27; TCGA HNSC -0.115; TCGA KIRC -0.213; TCGA KIRP -0.073; TCGA LIHC -0.073; TCGA LUAD -0.098; TCGA LUSC -0.198; TCGA OV -0.157; TCGA PAAD -0.236; TCGA UCEC -0.066 |
hsa-let-7b-5p | SLC38A9 | 9 cancers: CESC; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; OV; UCEC | miRNATAP | TCGA CESC -0.137; TCGA COAD -0.162; TCGA ESCA -0.182; TCGA KIRC -0.132; TCGA LIHC -0.174; TCGA LUAD -0.142; TCGA LUSC -0.158; TCGA OV -0.204; TCGA UCEC -0.196 |
hsa-let-7b-5p | CIAO1 | 10 cancers: COAD; ESCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; UCEC | miRNAWalker2 validate | TCGA COAD -0.083; TCGA ESCA -0.088; TCGA HNSC -0.098; TCGA KIRC -0.147; TCGA KIRP -0.071; TCGA LIHC -0.092; TCGA LUAD -0.058; TCGA LUSC -0.129; TCGA OV -0.086; TCGA UCEC -0.074 |
hsa-let-7b-5p | HSF2 | 9 cancers: COAD; HNSC; KIRC; LGG; LIHC; LUSC; OV; PAAD; STAD | miRNAWalker2 validate | TCGA COAD -0.136; TCGA HNSC -0.125; TCGA KIRC -0.181; TCGA LGG -0.056; TCGA LIHC -0.135; TCGA LUSC -0.174; TCGA OV -0.227; TCGA PAAD -0.206; TCGA STAD -0.165 |
hsa-let-7b-5p | RRP8 | 9 cancers: COAD; HNSC; KIRP; LIHC; LUSC; PAAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA COAD -0.133; TCGA HNSC -0.176; TCGA KIRP -0.14; TCGA LIHC -0.117; TCGA LUSC -0.089; TCGA PAAD -0.133; TCGA SARC -0.124; TCGA THCA -0.139; TCGA STAD -0.093 |
hsa-let-7b-5p | SCML2 | 9 cancers: COAD; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; UCEC | miRNAWalker2 validate | TCGA COAD -0.362; TCGA KIRC -0.279; TCGA KIRP -0.371; TCGA LIHC -0.293; TCGA LUAD -0.481; TCGA LUSC -0.862; TCGA OV -0.224; TCGA PAAD -0.643; TCGA UCEC -0.293 |
hsa-let-7b-5p | ARG2 | 9 cancers: COAD; KIRC; KIRP; LIHC; LUAD; OV; PAAD; SARC; STAD | MirTarget | TCGA COAD -0.143; TCGA KIRC -0.996; TCGA KIRP -0.257; TCGA LIHC -0.176; TCGA LUAD -0.187; TCGA OV -0.173; TCGA PAAD -0.474; TCGA SARC -0.186; TCGA STAD -0.135 |
hsa-let-7b-5p | ZNF248 | 9 cancers: COAD; ESCA; HNSC; LGG; LUAD; LUSC; PAAD; STAD; UCEC | miRNATAP | TCGA COAD -0.085; TCGA ESCA -0.178; TCGA HNSC -0.201; TCGA LGG -0.086; TCGA LUAD -0.059; TCGA LUSC -0.125; TCGA PAAD -0.218; TCGA STAD -0.163; TCGA UCEC -0.086 |
hsa-let-7b-5p | AARSD1 | 9 cancers: HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD | miRNAWalker2 validate | TCGA HNSC -0.247; TCGA KIRP -0.169; TCGA LGG -0.063; TCGA LIHC -0.221; TCGA LUAD -0.156; TCGA LUSC -0.207; TCGA PAAD -0.232; TCGA SARC -0.191; TCGA STAD -0.183 |
hsa-let-7b-5p | DRG2 | 9 cancers: HNSC; KIRP; LIHC; LUAD; OV; PAAD; SARC; THCA; STAD | miRNAWalker2 validate | TCGA HNSC -0.127; TCGA KIRP -0.084; TCGA LIHC -0.152; TCGA LUAD -0.119; TCGA OV -0.066; TCGA PAAD -0.182; TCGA SARC -0.262; TCGA THCA -0.07; TCGA STAD -0.095 |
hsa-let-7b-5p | FXR2 | 9 cancers: HNSC; KIRC; KIRP; LGG; LIHC; OV; PAAD; THCA; STAD | miRNAWalker2 validate | TCGA HNSC -0.103; TCGA KIRC -0.106; TCGA KIRP -0.104; TCGA LGG -0.058; TCGA LIHC -0.057; TCGA OV -0.12; TCGA PAAD -0.413; TCGA THCA -0.115; TCGA STAD -0.111 |
hsa-let-7b-5p | POLL | 10 cancers: HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; PRAD; THCA; STAD | MirTarget | TCGA HNSC -0.218; TCGA KIRP -0.097; TCGA LGG -0.13; TCGA LIHC -0.197; TCGA LUAD -0.067; TCGA LUSC -0.124; TCGA PAAD -0.374; TCGA PRAD -0.07; TCGA THCA -0.056; TCGA STAD -0.078 |
hsa-let-7b-5p | SYT1 | 9 cancers: KIRC; LIHC; LUAD; LUSC; OV; PRAD; SARC; THCA; UCEC | miRNATAP | TCGA KIRC -0.941; TCGA LIHC -0.423; TCGA LUAD -0.579; TCGA LUSC -0.649; TCGA OV -0.338; TCGA PRAD -0.327; TCGA SARC -0.479; TCGA THCA -0.758; TCGA UCEC -0.366 |
Enriched cancer pathways of putative targets